TSS:Hg 183700.1

Basic information about the TSS

---

TSS ID: hg_183700.1 Species: human Chr: chr20		Start: 18588040 End: 18588068 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000377452.4 NM_001318043 NM_080820 Distance: 0 GeneID: 92675 HGNC/MGI_ID: HGNC:16219 UniProt_ID: Q8TEA8

Gene_name: D-aminoacyl-tRNA deacylase 1 Gene_symbol: DTD1 Gene_synonyms: DUEB MGC119131 MGC41905 bA379J5.3 bA555E18.1 pqn-68 Gene_source: HGNC:16219

TATA-Box annotation

---

Distance to TSS:	0
Nearest PromoterID:	NM_001318043
Entrez ID:	92675
Nearest Unigene:	Hs.659442
Nearest Refseq:	NM_080820
Nearest Ensembl:	ENSG00000125821
Gene Name:	D-aminoacyl-tRNA deacylase 1
Gene Alias:	C20orf88|DTD|DUE-B|DUEB|HARS2|pqn-68
Gene Description:	D-aminoacyl-tRNA deacylase 1
Gene Type:	protein-coding
CpG%:	0.145
GC%:	0.78607
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@DTD1 p2@DTD1 p3@DTD1 p4@DTD1
Sample		p1@DTD1	p2@DTD1	p3@DTD1	p4@DTD1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	23.18	14.22	7.01	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	23.27	13.15	6.27	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	23.34	9.65	5.40	1.93
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	22.66	7.69	4.16	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	20.02	12.60	5.62	1.57
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	20.35	9.50	7.56	1.74
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	28.32	11.11	6.97	2.83
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	22.53	8.24	7.02	1.21
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	21.16	12.18	4.70	1.71
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	21.45	4.06	2.90	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	24.25	6.06	3.23	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	21.95	4.47	4.88	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	8.22	6.45	2.90	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	7.67	6.16	2.86	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	6.81	6.37	1.54	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	10.06	4.78	2.01	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	6.77	4.37	2.40	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	4.64	5.91	2.11	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	8.53	6.93	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	8.12	7.67	1.96	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	8.42	7.35	1.34	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	8.29	6.04	2.07	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	9.05	6.46	2.33	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	7.52	8.01	0.97	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	7.48	5.93	1.55	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	6.65	4.43	2.22	1.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	9.34	4.95	3.30	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	8.72	7.31	1.18	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	5.98	5.33	1.94	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	8.69	8.51	1.27	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	9.00	5.44	1.05	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	9.38	4.49	2.54	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	7.39	5.91	2.32	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	11.88	7.75	2.80	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	8.04	6.17	2.62	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	6.52	8.62	2.11	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	7.15	7.56	0.82	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	8.26	6.04	2.42	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	7.83	7.56	3.24	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	7.44	8.64	0.96	3.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	7.76	6.82	1.18	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	9.22	7.17	1.61	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	9.07	6.96	2.74	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	10.49	5.77	1.92	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	6.83	6.02	2.01	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	6.28	6.51	2.09	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	6.48	5.76	2.40	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	10.13	6.56	1.49	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	7.18	6.70	1.44	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	6.47	5.66	2.63	2.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	8.20	6.35	2.05	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	9.56	8.89	1.78	2.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	41.98	41.98	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	6.74	7.81	1.06	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	9.94	3.31	2.98	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	16.78	8.39	4.19	5.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	12.86	3.67	3.21	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	7.45	7.13	0.97	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	4.50	7.39	1.61	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	9.43	5.34	2.20	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	6.35	4.23	1.41	3.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	5.61	6.17	2.80	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	11.94	5.57	3.98	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	7.47	3.06	1.36	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	4.22	7.47	2.27	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	5.68	7.10	4.97	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	16.16	32.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	9.75	8.29	6.83	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	9.42	9.42	1.98	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	7.51	8.91	3.75	3.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	9.60	6.29	5.96	3.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	7.42	7.42	3.71	4.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	9.17	8.26	5.50	5.81
Adipocyte - breast, donor1	11376-118A8	13.46	6.49	4.59	3.01
Adipocyte - breast, donor2	11327-117E4	13.15	5.29	2.25	2.41
Adipocyte - omental, donor1	11473-119C6	13.49	7.76	5.73	2.67
Adipocyte - omental, donor2	11474-119C7	8.22	4.48	5.23	1.49
Adipocyte - omental, donor3	11475-119C8	11.05	5.36	3.01	1.34
Adipocyte - perirenal, donor1	11476-119C9	13.40	6.38	4.47	3.19
Adipocyte - subcutaneous, donor1	11259-116F8	5.50	2.20	3.30	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	9.94	7.68	4.97	4.97
Adipocyte - subcutaneous, donor3	11408-118E4	13.03	8.34	2.26	1.74
Adipocyte differentiation, day04, donor1	13019-139D4	9.58	4.69	2.93	2.74
Adipocyte differentiation, day04, donor2	13022-139D7	8.75	3.86	1.80	2.57
Adipocyte differentiation, day04, donor3	13025-139E1	20.63	6.13	3.07	5.30
Adipocyte differentiation, day04, donor4	13028-139E4	14.70	3.53	1.76	2.94
Adipocyte differentiation, day08, donor1	13020-139D5	9.65	2.90	1.53	2.09
Adipocyte differentiation, day08, donor2	13023-139D8	10.01	1.61	1.94	2.58
Adipocyte differentiation, day08, donor3	13026-139E2	7.46	2.13	4.27	3.73
Adipocyte differentiation, day08, donor4	13029-139E5	10.57	5.01	2.78	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	10.81	3.33	2.50	3.33
Adipocyte differentiation, day12, donor2	13024-139D9	10.30	2.51	2.26	3.52
Adipocyte differentiation, day12, donor3	13027-139E3	10.80	2.95	2.29	3.27
Adipocyte differentiation, day12, donor4	13030-139E6	7.31	5.18	0.91	1.52
Alveolar Epithelial Cells, donor1	11510-119G7	26.30	13.48	6.63	7.96
Alveolar Epithelial Cells, donor2	11590-120G6	16.14	8.96	2.51	2.87
Alveolar Epithelial Cells, donor3	11671-122G6	13.18	11.98	3.59	4.79
Amniotic Epithelial Cells, donor1	11533-120A3	22.49	17.99	5.58	6.48
Amniotic Epithelial Cells, donor2	11613-122A2	15.06	10.04	1.67	10.04
Amniotic Epithelial Cells, donor3	11694-123A2	20.75	17.87	8.42	9.66
Anulus Pulposus Cell, donor1	11248-116E6	22.43	17.74	6.98	3.09
Anulus Pulposus Cell, donor2	11463-119B5	17.39	8.82	3.92	4.41
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	16.62	6.74	10.33	7.64
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	19.54	9.99	6.51	6.08
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	4.28	6.42	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	15.25	11.36	7.17	6.58
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	15.18	13.91	6.32	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	15.84	5.94	5.94	2.64
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	17.87	6.50	4.22	4.87
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	15.05	15.53	4.37	7.28
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	14.85	7.72	5.94	4.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	19.59	13.18	6.03	6.40
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	13.06	9.43	8.71	9.43
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	15.05	13.79	5.02	3.76
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	17.46	12.36	5.60	5.60
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	20.47	13.65	9.55	15.01
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	10.71	9.20	6.03	3.77
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	23.04	9.64	6.97	6.97
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	17.19	9.26	7.18	7.56
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	16.30	10.16	5.61	5.08
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	20.48	14.63	3.90	3.90
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	14.60	9.62	5.97	5.97
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	14.41	6.00	7.20	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	7.08	3.54	14.16
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	13.72	6.69	7.55	5.66
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	0.00	0.00	8.39
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	16.50	6.80	4.37	7.28
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	20.87	15.18	6.83	7.59
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	21.80	7.27	7.27	4.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	16.53	14.25	5.70	9.12
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	14.54	8.34	7.05	6.63
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	12.13	7.48	6.71	4.13
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	11.26	11.73	5.16	7.04
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	10.61	11.90	5.47	6.75
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	20.69	6.42	5.71	4.99
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	16.96	11.70	9.94	3.51
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	16.26	9.33	6.62	4.22
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	15.44	11.88	11.88	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	13.73	7.63	8.65	5.59
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	13.24	10.19	4.84	5.09
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	15.88	5.08	4.45	6.35
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	20.28	9.06	4.75	10.36
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	15.66	10.16	5.72	6.56
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	12.18	8.12	5.80	3.77
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	22.67	13.23	5.67	6.61
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	13.39	9.32	6.44	6.95
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	23.16	4.63	6.95	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	29.58	8.45	2.11	10.56
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	12.86	7.72	7.72	7.93
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	21.66	10.23	2.41	3.01
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	16.04	8.02	5.10	6.56
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	15.63	7.13	5.29	6.21
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	17.85	10.20	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	11.95	7.63	3.05	5.85
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	14.66	11.15	6.40	5.37
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	13.46	7.65	8.57	3.98
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	16.25	10.04	4.78	7.17
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	14.63	6.65	4.21	5.99
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	1.53	6.10	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	19.94	7.75	5.54	9.97
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	16.15	7.68	6.88	6.09
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	13.08	8.72	4.72	2.54
Astrocyte - cerebellum, donor1	11500-119F6	24.32	15.11	7.12	8.47
Astrocyte - cerebellum, donor2	11580-120F5	20.71	15.58	5.31	7.19
Astrocyte - cerebellum, donor3	11661-122F5	15.73	12.17	5.66	5.87
Astrocyte - cerebral cortex, donor1	11235-116D2	33.12	27.89	10.46	9.06
Astrocyte - cerebral cortex, donor2	11316-117D2	33.81	22.00	10.35	9.87
Astrocyte - cerebral cortex, donor3	11392-118C6	42.51	21.03	11.49	11.93
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	39.68	26.72	8.95	6.77
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	38.59	26.18	6.89	7.52
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	36.76	24.12	9.10	6.15
Basophils, donor1	12241-129G9	8.37	7.32	1.57	3.14
Basophils, donor2	12242-129H1	25.26	10.10	1.80	5.05
Basophils, donor3	12243-129H2	8.97	5.00	1.18	1.76
Bronchial Epithelial Cell, donor1	11511-119G8	12.07	14.66	4.53	5.39
Bronchial Epithelial Cell, donor2	11591-120G7	9.60	6.86	2.74	3.20
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	14.35	7.17	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	24.48	16.95	5.65	8.16
Bronchial Epithelial Cell, donor5	11457-119A8	19.13	19.13	8.73	11.02
Bronchial Epithelial Cell, donor6	11461-119B3	38.92	29.48	11.28	7.37
Bronchial Epithelial Cell, donor7	11769-123I5	11.16	12.78	5.40	5.58
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.21	0.62	0.31	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	14.67	34.24	8.38	10.01
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	22.06	27.82	5.44	6.72
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	10.34	10.34
CD14+ Monocytes, donor1	11224-116B9	7.89	5.07	0.56	2.82
CD14+ Monocytes, donor2	11305-117B9	11.88	7.61	1.48	3.90
CD14+ Monocytes, donor3	11381-118B4	11.20	4.83	0.88	3.07
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	22.08	5.09	1.13	2.83
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	17.06	4.17	1.52	3.41
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	12.16	6.25	2.96	4.60
CD14+ monocytes - mock treated, donor1	11863-125A9	6.07	1.16	0.14	1.59
CD14+ monocytes - mock treated, donor2	11873-125C1	7.85	3.92	1.21	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	4.97	1.18	0.71	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	3.35	1.34	0.84	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	5.80	2.48	0.28	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	6.69	2.98	0.74	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	6.85	0.39	0.39	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	6.77	3.20	1.07	1.60
CD14+ monocytes - treated with BCG, donor3	11880-125C8	7.40	4.57	1.09	1.74
CD14+ monocytes - treated with Candida, donor1	11868-125B5	4.21	3.04	0.94	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	7.92	4.22	0.53	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	5.55	3.33	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	4.16	1.49	0.15	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	6.59	3.19	0.60	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	4.58	2.08	0.42	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	4.35	1.14	0.46	1.37
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	4.07	3.17	0.45	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	3.93	1.75	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	2.42	1.08	0.00	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	6.63	4.01	0.70	1.22
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	6.73	2.52	0.00	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	3.67	1.47	0.18	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	5.64	2.82	0.35	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.51	0.44	0.00	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	5.23	2.27	0.17	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	4.46	2.60	1.12	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	6.68	2.37	0.43	1.94
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	3.28	3.69	1.23	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	4.64	3.01	0.23	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	3.71	2.32	0.00	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	23.32	6.76	0.65	2.18
CD14+CD16+ Monocytes, donor2	11801-124D1	19.17	7.62	2.77	3.46
CD14+CD16+ Monocytes, donor3	11912-125G4	19.28	10.61	1.95	3.68
CD14+CD16- Monocytes, donor1	11788-124B6	12.77	8.41	1.71	3.89
CD14+CD16- Monocytes, donor2	11799-124C8	14.84	7.51	1.75	4.02
CD14+CD16- Monocytes, donor3	11910-125G2	13.16	8.03	2.68	2.90
CD14-CD16+ Monocytes, donor1	11790-124B8	25.01	10.46	2.04	3.83
CD14-CD16+ Monocytes, donor2	11800-124C9	27.88	10.10	3.07	2.63
CD14-CD16+ Monocytes, donor3	11911-125G3	33.06	11.79	2.32	4.84
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	6.10	20.32	0.00	6.10
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	10.17	16.95	8.14	7.46
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	12.43	14.50	7.25	4.14
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	10.66	15.99	5.33	6.40
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	7.50	12.33	9.65	5.90
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	12.63	15.44	2.81	5.62
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	11.77	9.41	3.14	3.14
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	6.59	15.82	11.86	5.27
CD19+ B Cells, donor1	11544-120B5	4.93	11.51	8.22	4.11
CD19+ B Cells, donor2	11624-122B4	12.33	14.51	5.80	7.25
CD19+ B Cells, donor3	11705-123B4	7.57	13.63	7.07	5.55
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	10.10	6.46	0.40	2.42
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	5.99	5.19	1.20	2.80
CD34+ Progenitors, donor1	11545-120B6	20.08	23.09	7.03	8.03
CD34+ Progenitors, donor2	11625-122B5	14.61	17.42	5.06	8.43
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	18.04	27.81	5.26	13.15
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	22.55	23.45	8.57	7.22
CD4+ T Cells, donor1	11225-116C1	17.85	7.86	4.28	4.28
CD4+ T Cells, donor2	11306-117C1	29.39	11.02	2.45	9.80
CD4+ T Cells, donor3	11382-118B5	21.04	10.06	5.79	5.49
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	12.76	5.62	1.02	1.79
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	16.84	5.84	1.57	1.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	13.80	4.89	1.72	2.59
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	30.82	12.33	4.27	6.64
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	35.82	18.96	0.70	14.05
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	39.55	0.00	3.30	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	26.45	7.37	0.87	2.46
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	23.05	5.59	2.20	3.39
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	20.15	6.29	1.61	1.29
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	26.90	10.31	3.14	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	33.19	10.13	3.84	5.94
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	33.88	11.00	2.20	1.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	31.62	6.75	1.69	3.79
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	22.85	5.40	1.45	1.45
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	29.40	8.69	3.01	1.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	19.58	10.06	2.72	6.53
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	34.30	11.79	3.22	10.72
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	28.69	25.11	1.79	8.97
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	34.86	10.75	3.15	2.04
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	22.31	9.10	2.60	2.17
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	31.10	9.88	3.36	2.73
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	30.84	13.65	3.03	6.07
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	32.93	19.06	4.77	8.67
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	32.69	20.05	2.18	6.97
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	30.19	13.36	5.94	5.44
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	32.31	15.69	4.62	12.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	36.29	13.96	4.19	12.56
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	40.43	11.35	3.60	5.26
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	40.98	18.16	3.93	7.12
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	29.26	10.78	3.08	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	41.90	10.74	5.01	3.58
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	38.78	24.93	6.92	6.92
CD8+ T Cells, donor1	11226-116C2	22.59	11.13	3.60	5.89
CD8+ T Cells, donor2	11307-117C2	35.67	12.39	2.63	4.13
CD8+ T Cells, donor3	11383-118B6	26.01	14.14	2.52	5.05
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	17.89	9.63	1.84	1.15
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	21.33	9.11	1.68	1.92
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	19.15	4.65	1.37	1.92
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	23.42	6.90	2.10	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	18.00	8.64	1.20	2.88
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	23.19	8.87	1.59	1.59
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	20.86	9.56	3.48	2.61
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	18.42	8.95	1.32	2.11
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	15.48	7.50	3.05	1.64
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	21.43	9.66	3.62	2.42
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	26.15	8.42	3.20	2.03
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	19.72	12.26	2.66	3.20
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	13.57	7.00	0.88	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	13.66	10.02	0.91	2.28
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	5.22	4.48	1.49	2.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	20.89	11.89	2.52	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	19.28	10.07	0.86	3.16
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	23.57	8.01	2.12	1.41
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	26.62	14.89	2.85	1.90
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	21.53	9.84	3.08	3.69
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	21.80	7.37	2.89	1.92
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	17.98	12.24	1.91	2.29
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	23.65	9.06	3.94	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	23.45	7.56	2.27	2.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	28.91	7.23	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	24.48	7.69	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	14.02	15.03	1.00	4.01
Cardiac Myocyte, donor1	11525-119I4	18.28	9.14	5.48	0.00
Cardiac Myocyte, donor2	11605-120I3	17.79	11.36	5.93	5.93
Cardiac Myocyte, donor3	11686-122I3	29.04	21.99	12.21	7.47
Chondrocyte - de diff, donor1	11261-116G1	21.84	7.28	7.28	3.47
Chondrocyte - de diff, donor2	11338-117F6	14.57	11.02	4.62	2.84
Chondrocyte - de diff, donor3	11410-118E6	19.91	11.49	5.46	4.44
Chondrocyte - re diff, donor2	11339-117F7	31.33	24.17	10.74	8.06
Chondrocyte - re diff, donor3	11411-118E7	15.37	15.37	6.47	6.07
Ciliary Epithelial Cells, donor1	11242-116D9	25.71	20.31	5.05	7.80
Ciliary Epithelial Cells, donor2	11323-117D9	22.66	17.32	7.91	7.91
Ciliary Epithelial Cells, donor3	11399-118D4	27.88	19.91	4.16	7.17
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	26.13	17.42	4.03	3.39
Corneal Epithelial Cells, donor1	11526-119I5	17.13	20.86	3.07	3.07
Corneal Epithelial Cells, donor2	11606-120I4	19.34	9.10	4.55	9.10
Corneal Epithelial Cells, donor3	11687-122I4	26.07	18.92	6.65	5.37
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	16.18	3.63	1.16	0.83
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	15.77	2.52	1.26	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	24.15	6.90	3.45	6.90
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	13.82	3.13	1.08	1.30
Dendritic Cells - plasmacytoid, donor1	11228-116C4	4.44	1.71	2.05	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	2.61	5.22	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	3.87	4.36	0.48	1.45
Endothelial Cells - Aortic, donor0	11207-116A1	33.19	26.35	14.18	7.84
Endothelial Cells - Aortic, donor1	11263-116G3	24.06	17.60	7.63	9.98
Endothelial Cells - Aortic, donor2	11340-117F8	25.17	23.75	7.35	5.37
Endothelial Cells - Aortic, donor3	11412-118E8	24.77	16.51	11.40	8.65
Endothelial Cells - Artery, donor1	11264-116G4	16.29	17.16	7.27	4.36
Endothelial Cells - Artery, donor2	11341-117F9	24.47	23.29	4.71	5.18
Endothelial Cells - Artery, donor3	11413-118E9	29.80	18.76	6.31	7.71
Endothelial Cells - Lymphatic, donor1	11236-116D3	13.96	7.98	2.88	2.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	9.74	7.61	3.35	3.35
Endothelial Cells - Lymphatic, donor3	11393-118C7	10.71	7.05	1.41	4.79
Endothelial Cells - Microvascular, donor1	11265-116G5	21.69	14.26	3.27	5.35
Endothelial Cells - Microvascular, donor2	11342-117G1	22.39	18.74	5.21	3.12
Endothelial Cells - Microvascular, donor3	11414-118F1	15.03	11.06	2.55	2.27
Endothelial Cells - Thoracic, donor1	11266-116G6	30.01	27.21	6.00	8.40
Endothelial Cells - Thoracic, donor2	11343-117G2	20.96	13.63	6.29	6.29
Endothelial Cells - Umbilical vein, donor1	11243-116E1	25.84	25.35	5.84	7.45
Endothelial Cells - Umbilical vein, donor2	11324-117E1	17.82	18.90	7.17	5.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	19.78	20.40	5.86	9.40
Endothelial Cells - Vein, donor1	11267-116G7	13.65	15.93	4.55	9.10
Endothelial Cells - Vein, donor2	11344-117G3	13.27	16.76	4.89	6.99
Endothelial Cells - Vein, donor3	11416-118F3	24.18	26.69	9.58	8.01
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	15.25
Eosinophils, donor2	12245-129H4	3.30	6.60	1.65	3.30
Eosinophils, donor3	12246-129H5	3.57	0.00	7.13	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	14.42	13.44	4.64	2.93
Esophageal Epithelial Cells, donor2	11587-120G3	16.64	10.40	4.16	8.32
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	32.54	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	20.12	9.85	10.26	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	13.47	7.88	3.18	3.39
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	23.62	12.89	8.23	3.58
Fibroblast - Aortic Adventitial, donor1	11245-116E3	35.41	18.07	9.34	4.85
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	17.20	7.51	4.09	3.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	23.31	14.87	8.65	6.01
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	15.02	6.59	3.16	2.11
Fibroblast - Aortic Adventitial, donor3	11401-118D6	33.88	19.60	8.97	5.65
Fibroblast - Cardiac, donor1	11268-116G8	23.13	7.71	7.71	7.71
Fibroblast - Cardiac, donor2	11345-117G4	18.19	9.10	3.79	4.55
Fibroblast - Cardiac, donor3	11417-118F4	18.77	11.83	5.36	3.79
Fibroblast - Cardiac, donor4	11452-119A3	18.49	14.55	4.24	4.85
Fibroblast - Cardiac, donor5	11456-119A7	29.57	18.15	8.50	8.38
Fibroblast - Cardiac, donor6	11460-119B2	28.80	15.31	6.67	5.31
Fibroblast - Choroid Plexus, donor1	11492-119E7	18.36	9.38	3.48	5.90
Fibroblast - Choroid Plexus, donor2	11572-120E6	14.67	6.04	3.88	4.75
Fibroblast - Choroid Plexus, donor3	11653-122E6	8.79	10.25	2.93	11.72
Fibroblast - Conjunctival, donor1	11531-120A1	40.59	33.44	10.84	5.07
Fibroblast - Conjunctival, donor3	11692-122I9	19.33	11.70	3.90	1.19
Fibroblast - Dermal, donor1	11269-116G9	23.24	12.21	6.57	6.57
Fibroblast - Dermal, donor2	11346-117G5	26.89	37.73	8.02	8.49
Fibroblast - Dermal, donor3	11418-118F5	33.61	24.66	8.82	7.74
Fibroblast - Dermal, donor4	11450-119A1	40.13	24.19	7.69	7.91
Fibroblast - Dermal, donor5	11454-119A5	39.78	25.64	9.25	9.77
Fibroblast - Dermal, donor6	11458-119A9	44.02	26.48	13.32	12.34
Fibroblast - Gingival, donor1	11237-116D4	29.99	19.57	6.46	5.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	27.77	11.79	6.03	4.19
Fibroblast - Gingival, donor2	11318-117D4	32.68	24.38	10.67	8.43
Fibroblast - Gingival, donor3	11394-118C8	23.01	13.73	5.41	3.67
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	9.35	4.16	3.12	7.27
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	13.74	5.46	2.82	3.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	31.02	13.41	7.02	4.05
Fibroblast - Gingival, donor6 (control)	11922-125H5	30.56	11.90	5.27	4.73
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	10.94	3.88	2.12	3.18
Fibroblast - Gingival, donor7 (control)	11924-125H7	26.76	9.07	5.12	3.51
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	32.32	12.68	5.18	3.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	33.68	10.53	7.35	5.59
Fibroblast - Gingival, donor9 (control)	11927-125I1	13.35	6.90	3.96	3.67
Fibroblast - Lung, donor1	11270-116H1	25.83	9.52	1.36	5.44
Fibroblast - Lung, donor2	11347-117G6	29.84	22.38	5.97	2.98
Fibroblast - Lung, donor3	11419-118F6	30.81	26.38	8.86	8.23
Fibroblast - Lymphatic, donor1	11506-119G3	41.65	30.82	12.50	12.50
Fibroblast - Lymphatic, donor2	11586-120G2	20.98	9.79	1.40	5.59
Fibroblast - Lymphatic, donor3	11667-122G2	16.79	7.56	3.08	5.04
Fibroblast - Mammary, donor1	11540-120B1	28.42	21.92	8.93	9.74
Fibroblast - Mammary, donor2	11620-122A9	31.95	23.97	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	35.74	29.78	17.87	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	33.56	28.71	8.73	7.76
Fibroblast - Periodontal Ligament, donor2	11319-117D5	41.86	28.97	11.68	8.34
Fibroblast - Periodontal Ligament, donor3	11395-118C9	24.78	21.73	8.87	7.04
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	20.23	11.45	6.11	5.34
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	24.03	10.26	5.13	3.78
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	17.51	6.73	3.02	2.20
Fibroblast - Pulmonary Artery, donor1	11250-116E8	25.98	16.80	8.29	6.08
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	26.01	20.73	6.71	8.94
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	23.39	14.70	4.68	5.35
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	24.91	17.79	9.09	9.88
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	19.84	9.13	4.37	3.57
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	10.30	9.95	6.57	3.91
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	14.39	8.87	6.90	4.73
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	18.05	6.62	5.11	5.72
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	26.56	11.77	7.77	5.83
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	18.47	6.07	4.30	4.81
Fibroblast - skin normal, donor1	11553-120C5	17.23	11.98	4.27	6.07
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	14.64	7.22	3.01	3.01
Fibroblast - skin normal, donor2	11561-120D4	27.53	10.65	6.63	4.82
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	21.16	8.46	3.32	3.93
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	12.51	8.20	4.23	4.39
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	15.04	10.26	2.56	4.27
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	12.81	8.21	2.63	3.28
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	24.29	11.93	8.42	5.97
Fibroblast - skin walker warburg, donor1	11554-120C6	27.16	16.70	8.43	6.58
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	22.90	10.19	5.18	6.43
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	0.00	88.64	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	23.53	8.72	3.49	5.23
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	17.86	10.92	6.59	6.93
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	12.49	9.89	3.90	7.29
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	12.26	8.69	2.81	4.85
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	32.92	32.92	15.31	10.72
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	45.30	28.08	12.76	8.29
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	31.95	32.23	15.40	16.26
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	19.85	22.61	5.24	6.07
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	33.11	13.47	6.39	4.79
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	23.58	24.57	10.30	10.10
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	26.17	21.15	2.11	6.34
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	23.48	11.42	4.24	5.22
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	35.38	33.61	14.15	11.94
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	28.69	30.38	10.18	9.61
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	22.17	21.06	8.37	7.51
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	20.15	19.61	6.45	4.84
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	16.85	18.21	6.19	6.32
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	20.90	22.56	4.15	5.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	16.26	17.89	4.47	5.90
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	18.71	10.27	4.56	9.13
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	18.44	16.32	5.36	8.10
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	14.64	11.80	6.78	6.12
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	22.16	22.46	5.32	5.02
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	28.29	18.44	6.20	6.36
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	14.52	14.08	5.81	6.26
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	28.63	20.16	6.05	6.25
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	35.79	21.71	5.26	7.80
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	24.47	12.59	3.64	6.65
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	20.81	17.27	4.99	8.84
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	19.47	16.74	4.10	6.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	28.22	21.47	6.31	9.07
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	28.87	16.56	5.66	6.91
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	24.30	13.68	4.29	7.76
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	24.55	20.01	4.75	11.55
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	28.59	19.02	6.57	10.49
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	27.35	15.84	4.50	6.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	16.53	15.65	4.19	4.85
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	18.33	21.03	7.63	11.07
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	20.10	17.83	4.86	7.62
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	17.64	16.36	11.87	8.98
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	23.21	20.37	8.05	8.43
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	23.09	15.18	5.54	6.49
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	18.55	14.60	6.39	7.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	22.89	18.19	7.94	10.98
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	17.78	13.61	6.37	5.27
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	12.62	10.66	7.01	5.89
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	13.98	13.61	4.72	7.31
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	20.86	12.03	4.81	8.02
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	16.22	12.09	4.74	7.96
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	16.32	14.25	6.48	10.62
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	18.98	16.81	5.69	5.69
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	15.67	9.95	4.24	5.16
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	14.91	12.06	3.95	4.39
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	16.86	8.93	4.96	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	13.85	10.95	5.67	7.65
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	9.08	10.49	6.25	8.27
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	10.93	9.15	1.27	5.08
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	31.05	29.66	12.14	11.15
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	17.26	32.66	14.33	10.17
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	25.78	39.08	18.82	13.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	29.10	29.10	4.69	5.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	29.95	25.71	7.06	5.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	36.44	31.36	4.15	2.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	47.02	22.27	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	28.62	22.05	7.35	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	30.48	24.07	1.60	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	43.47	20.87	5.22	10.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	30.60	14.32	6.18	5.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	29.65	15.65	3.29	6.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	26.66	3.33	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	26.57	16.50	5.87	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	29.09	14.05	2.61	6.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	26.84	17.62	4.19	5.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	30.85	19.40	4.13	7.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	31.93	15.28	6.45	5.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	18.79	16.71	10.44	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	49.82	29.21	5.15	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	25.75	17.76	5.03	5.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	35.58	13.55	1.69	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	43.91	24.02	6.21	6.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	41.42	14.04	6.21	5.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	21.07	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	38.83	16.15	3.46	6.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	25.43	9.78	4.89	4.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	30.77	14.05	7.36	5.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	27.74	23.89	5.78	6.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	24.65	14.04	4.11	5.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	19.88	22.36	2.48	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	29.73	17.93	4.25	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	24.74	19.31	6.64	6.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	21.87	21.36	6.61	6.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	30.71	18.35	4.39	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	27.63	20.72	6.91	10.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	15.35	23.61	5.90	15.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	22.17	15.17	4.67	8.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	20.19	17.12	7.02	8.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	14.41	16.11	1.70	9.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	23.28	12.54	4.18	5.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	31.06	14.56	4.85	8.25
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	21.68	7.99	2.28	3.42
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	19.13	8.32	2.08	1.66
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	25.86	5.62	3.37	3.37
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	12.69	8.56	4.76	2.22
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	14.20	12.53	2.09	2.51
Hep-2 cells mock treated, biol_rep1	11898-125E8	22.86	9.86	2.90	3.25
Hep-2 cells mock treated, biol_rep2	11899-125E9	22.45	10.13	4.22	3.21
Hep-2 cells mock treated, biol_rep3	11900-125F1	22.75	13.20	6.60	2.73
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	23.39	10.38	4.59	1.97
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	20.20	9.46	5.16	1.93
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	21.10	11.19	3.23	2.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	21.42	9.46	4.23	3.99
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	17.33	10.81	2.57	2.23
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	21.46	9.93	2.88	4.16
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	25.74	16.23	2.24	5.04
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	13.85	14.71	3.90	4.76
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	7.93	5.29	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	30.33	17.99	8.11	9.88
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	18.89	9.44	5.09	3.63
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	29.20	17.48	7.69	5.59
Hepatocyte, donor1	11523-119I2	15.74	7.26	2.42	0.00
Hepatocyte, donor2	11603-120I1	15.08	2.15	1.08	3.23
Hepatocyte, donor3	11684-122I1	16.57	6.14	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	1.31	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	7.87	6.29	5.24	4.72
Iris Pigment Epithelial Cells, donor1	11530-119I9	14.96	12.07	4.94	8.92
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	1.38	8.31	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	5.01	2.50	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	2.56	0.00	2.56	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	3.25	6.50	1.62	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	8.34	6.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	7.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	1.32	6.62	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	4.43	2.22	1.11	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	5.04	8.19	2.52	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	1.55	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	6.46	9.04	1.94	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	3.22	8.05	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	9.78	3.26	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	4.20	3.78	0.42	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	4.82	6.43	1.61	4.02
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	5.54	4.62	2.77	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	5.19	6.61	1.89	1.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	7.26	4.53	1.81	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	0.00	29.48
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	0.00	7.53	1.08	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	1.27	3.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	2.55	3.83	1.91	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	3.65	0.00	5.47
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	3.57	6.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	4.63	9.88	0.93	2.47
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	5.27	3.51	3.51	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	2.78	4.17	0.70	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2.21	6.64	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	7.85	1.74	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	4.50	2.25	2.25	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	13.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	6.40	5.33	2.13	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	4.16	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	2.85	2.85	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	5.52	2.76	2.76	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	3.03	0.00	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	11.63	5.29	0.00	3.17
Keratinocyte - epidermal, donor1	11272-116H3	21.13	13.38	4.90	4.32
Keratinocyte - epidermal, donor2	11349-117G8	19.91	15.81	7.03	5.27
Keratinocyte - epidermal, donor3	11421-118F8	37.67	27.26	8.61	7.48
Keratinocyte - oral, donor1	11251-116E9	29.40	36.67	4.99	6.13
Keratocytes, donor1	11527-119I6	39.54	24.76	11.00	8.25
Keratocytes, donor2	11607-120I5	28.12	21.09	12.89	7.03
Keratocytes, donor3	11688-122I5	17.19	14.62	6.72	4.15
Krukenberg tumor cell line:HSKTC	10687-109F3	54.95	50.55	15.39	21.98
Lens Epithelial Cells, donor1	11529-119I8	18.34	8.63	9.71	10.79
Lens Epithelial Cells, donor2	11609-120I7	17.53	19.61	4.50	5.31
Lens Epithelial Cells, donor3	11690-122I7	14.73	13.02	5.15	5.45
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	19.80	14.58	3.32	4.15
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	18.42	10.60	2.51	3.91
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	22.82	13.22	5.04	2.83
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	19.36	10.75	3.76	5.38
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	16.70	12.61	1.89	1.89
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	20.70	10.57	3.34	2.91
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	17.24	12.31	0.82	4.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	19.97	12.89	2.28	3.03
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	21.68	8.59	2.39	3.10
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	20.17	9.49	1.58	1.98
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	20.16	12.21	3.10	2.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	17.96	11.48	4.26	3.15
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	18.47	14.63	2.44	4.18
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	19.32	11.21	2.62	5.25
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	21.56	8.38	2.75	3.30
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	24.94	10.78	2.16	2.77
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	15.59	10.60	1.56	1.87
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	21.41	10.25	3.29	3.11
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	17.44	13.82	2.30	3.62
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	20.50	9.66	2.05	2.93
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	18.42	9.96	2.74	3.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	21.82	13.09	4.36	3.39
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	17.50	9.69	3.23	4.58
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	23.16	10.75	2.88	2.12
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	22.81	11.92	2.07	2.59
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	27.43	10.26	2.93	1.05
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	22.41	12.78	2.11	3.91
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	22.70	13.07	1.38	3.44
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	24.27	10.35	2.07	3.01
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	21.52	10.82	3.07	2.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	20.84	7.75	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	18.19	8.60	0.99	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	19.45	9.66	1.73	1.98
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	19.62	18.51	1.48	4.07
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	17.30	8.65	2.47	2.72
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	14.85	9.76	2.20	2.47
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	22.84	13.51	3.86	4.82
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	20.09	13.39	3.35	3.35
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	22.95	11.48	2.80	2.94
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	26.31	12.80	1.42	3.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	20.36	8.73	1.94	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	15.41	10.89	2.49	2.18
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	22.92	10.03	2.51	1.79
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	21.89	9.80	2.61	2.61
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	19.30	9.65	2.83	1.88
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	20.05	13.49	1.98	3.84
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	17.42	7.94	2.31	1.54
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	17.90	13.72	1.79	1.49
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	33.99	20.39	6.80	6.80
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	16.11	12.27	7.67	4.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	17.07	5.94	4.45	7.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	19.04	11.42	3.39	3.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	14.77	9.85	4.92	3.52
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	16.81	14.01	4.67	5.60
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	16.49	11.85	4.64	4.64
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	14.27	8.33	2.38	4.76
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	15.15	14.02	5.88	3.62
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	25.88	15.12	5.53	5.53
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	19.81	15.76	5.85	4.05
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	21.27	15.85	6.37	3.93
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	16.95	13.35	5.14	5.65
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	17.64	13.06	4.59	4.94
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	13.99	6.66	8.66	2.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	24.45	13.75	7.13	5.09
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	22.95	15.21	5.07	5.87
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	26.07	16.25	7.75	6.24
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	20.25	11.66	6.14	3.68
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	31.80	13.05	8.97	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	23.32	15.20	6.46	4.58
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	28.03	17.66	5.04	2.80
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	20.61	13.39	3.09	6.18
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	24.10	11.90	6.97	5.23
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	25.71	20.03	6.28	4.48
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	17.70	14.94	13.83	6.09
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	17.67	12.73	6.36	6.36
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	27.29	18.44	7.38	7.01
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	27.63	17.27	9.21	6.91
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	19.19	15.35	8.83	4.99
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	15.85	9.62	3.96	2.83
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	19.69	13.95	7.38	8.20
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	17.17	8.13	6.78	2.71
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	30.88	16.52	6.46	4.31
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	14.94	13.44	11.20	8.22
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	16.35	17.09	5.95	4.83
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	19.38	14.21	6.89	4.31
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	11.13	22.26	5.99	7.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	25.32	16.99	9.00	5.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	15.08	14.48	6.64	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	16.35	10.66	6.40	3.55
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	19.59	13.06	5.50	3.78
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	23.08	10.20	4.83	5.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	16.16	14.81	3.37	3.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	23.34	14.08	6.30	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	23.26	13.96	2.33	5.81
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	14.81	4.23	5.29	7.40
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	21.61	17.21	8.40	4.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	13.08	6.54	1.45	3.63
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	14.56	22.23	5.37	3.07
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	22.20	12.33	6.41	2.96
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	18.82	8.47	3.76	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	13.07	13.07	4.53	7.54
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	16.67	14.87	3.60	4.96
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	29.26	15.49	6.88	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	19.60	12.47	4.90	3.12
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	19.94	13.69	7.82	4.30
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	24.41	11.88	3.96	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	24.39	11.94	10.38	4.15
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	17.94	13.56	7.44	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	22.36	12.86	6.71	7.27
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	17.67	13.25	7.95	3.97
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	13.89	15.81	8.10	4.24
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	18.74	14.18	3.54	3.04
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	15.86	15.38	8.65	6.73
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	19.08	7.95	7.55	5.57
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	21.27	15.19	4.25	5.47
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	18.68	8.30	5.53	4.84
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	25.46	12.54	6.46	3.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	19.11	12.91	5.16	5.16
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	15.12	10.28	5.44	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	23.13	15.53	7.61	4.44
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	20.26	9.60	5.86	5.33
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	20.11	9.19	5.17	4.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	18.51	13.37	7.20	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	27.59	15.56	8.49	4.24
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	17.02	14.75	9.08	3.97
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	16.64	12.48	7.90	3.74
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	20.36	12.53	3.92	4.70
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	14.20	11.27	6.68	4.18
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	18.59	11.62	8.36	3.72
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	19.40	7.36	6.69	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	20.32	12.30	6.95	6.95
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	20.20	13.34	8.08	2.83
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	24.78	16.52	7.34	7.34
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	19.56	11.56	8.00	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	21.09	13.11	3.42	4.56
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	20.71	13.80	6.90	3.07
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	32.28	9.85	9.30	10.94
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	19.15	15.15	8.91	5.35
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	23.40	16.12	9.62	5.20
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	19.89	11.27	9.95	8.62
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	27.02	2.08	2.08	4.16
Macrophage - monocyte derived, donor1	11232-116C8	13.22	4.33	0.91	2.96
Macrophage - monocyte derived, donor2	11313-117C8	12.66	3.85	0.73	1.65
Macrophage - monocyte derived, donor3	11389-118C3	18.74	5.51	1.18	2.10
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	18.05	13.81	10.09	9.56
Mallassez-derived cells, donor2	11929-125I3	29.31	13.47	5.86	7.29
Mallassez-derived cells, donor3	11930-125I4	31.55	17.79	5.98	6.67
Mammary Epithelial Cell, donor1	11273-116H4	38.46	31.29	11.96	8.17
Mammary Epithelial Cell, donor2	11350-117G9	28.38	33.88	10.42	8.11
Mammary Epithelial Cell, donor3	11422-118F9	23.70	20.95	7.48	9.23
Mast cell - stimulated, donor1	11487-119E2	44.07	29.15	2.03	1.36
Mast cell, donor1	11563-120D6	17.52	17.63	2.70	2.38
Mast cell, donor2	11565-120D8	15.16	10.10	2.38	5.65
Mast cell, donor3	11566-120D9	15.98	11.71	2.93	3.83
Mast cell, donor4	11567-120E1	12.06	10.11	1.42	2.66
Mast cell, expanded and stimulated, donor5	11940-126A5	25.62	10.09	1.00	2.55
Mast cell, expanded and stimulated, donor8	11942-126A7	25.10	3.50	2.33	0.58
Mast cell, expanded, donor5	11939-126A4	36.71	12.50	2.75	2.75
Mast cell, expanded, donor8	11941-126A6	24.27	6.69	2.34	2.68
Melanocyte - dark, donor1	11502-119F8	14.33	12.64	4.58	3.88
Melanocyte - dark, donor2	11582-120F7	20.76	12.81	4.85	3.46
Melanocyte - dark, donor3	11663-122F7	20.72	17.53	5.22	6.52
Melanocyte - light, donor1	11274-116H5	14.81	8.46	3.29	3.06
Melanocyte - light, donor2	11351-117H1	13.65	10.92	1.36	8.87
Melanocyte - light, donor3	11423-118G1	11.27	9.54	4.34	7.81
Melanocyte, donor1 (MC+1)	12641-134G4	16.24	13.02	5.94	9.16
Melanocyte, donor2 (MC+2)	12739-135I3	9.14	5.11	1.34	2.96
Melanocyte, donor3 (MC+3)	12837-137B2	12.32	7.50	3.48	4.29
Meningeal Cells, donor1	11493-119E8	31.76	27.67	7.69	13.65
Meningeal Cells, donor2	11573-120E7	30.37	14.97	4.84	11.44
Meningeal Cells, donor3	11654-122E7	29.10	16.87	4.40	7.66
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	21.10	31.08	5.70	11.41
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	15.40	10.87	5.33	4.13
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	9.20	1.31	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	20.93	6.54	5.23	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	27.99	17.22	7.18	4.31
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	18.21	8.68	2.33	2.54
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	27.65	10.56	3.52	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	20.00	14.50	5.93	7.47
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	21.92	25.57	7.31	10.96
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	22.92	13.09	4.30	5.73
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	12.74	11.50	2.91	2.63
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	6.69	4.46	1.12	1.86
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	14.74	12.63	2.37	3.29
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	6.53	4.75	1.48	2.08
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	11.68	2.34	4.67
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	25.62	19.21	7.68	3.84
Mesenchymal stem cells - adipose, donor0	11217-116B2	21.62	17.01	8.86	8.15
Mesenchymal stem cells - hepatic, donor0	11218-116B3	14.70	15.64	5.00	2.50
Mesenchymal stem cells - umbilical, donor0	11214-116A8	20.32	29.75	9.43	7.26
Mesothelial Cells, donor1	11247-116E5	21.21	12.73	4.51	5.57
Mesothelial Cells, donor2	12156-128G5	21.02	12.01	6.51	5.51
Mesothelial Cells, donor3	11402-118D7	19.22	8.24	5.49	5.13
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	13.50	1.35	2.70	5.40
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	15.52	3.69	1.72	1.48
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	12.07	2.65	1.18	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	6.91	6.91	10.37
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	9.92	3.41	1.55	4.03
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	11.41	2.90	0.62	1.24
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	11.51	4.00	1.25	2.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	15.36	4.19	1.86	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	19.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	11.79	2.24	0.61	2.85
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	11.48	1.98	1.19	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	8.85	1.77	0.00	3.54
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	15.58	3.80	1.90	2.28
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	9.21	0.00	6.58	3.95
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	7.64	2.33	1.27	2.33
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	6.45	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	9.24	1.79	0.89	2.38
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	9.03	2.51	0.75	1.76
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	9.51	1.66	0.95	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	9.40	4.42	3.32	2.21
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	10.36	1.38	1.15	1.15
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	10.94	2.10	1.26	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	6.32	2.65	1.22	1.83
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	12.23	2.15	0.86	1.29
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	9.56	2.22	1.11	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	10.29	2.63	1.10	2.41
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	9.13	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	1.66	3.31	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	8.15	4.89	0.54	1.63
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	6.47	2.06	1.18	1.47
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	0.00	0.00	5.45
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	11.53	1.92	0.48	1.44
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	7.60	2.00	1.20	1.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	10.97	1.37	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	8.01	1.50	0.50	3.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	8.32	1.31	1.31	1.75
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	3.31	2.21	1.10	3.31
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.68	1.92	1.28	2.56
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	11.40	2.73	0.99	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	5.57	3.48	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	13.33	3.42	2.05	1.71
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	3.50	3.06	0.44	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	8.88	2.13	1.78	1.78
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	11.50	1.68	0.84	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	8.73	2.49	0.83	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	7.58	1.17	1.75	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	8.14	1.21	0.90	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	7.93	0.83	0.42	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	8.31	0.00	0.92	2.77
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	13.09	0.00	1.71	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	10.36	0.83	0.83	0.83
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	11.40	2.59	0.26	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	10.30	1.29	0.86	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	9.53	3.81	1.27	2.54
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	7.21	1.07	1.87	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	6.59	1.50	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	8.19	1.70	0.99	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	8.28	1.59	0.96	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	5.97	0.66	0.66	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	6.83	1.52	1.14	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	9.66	2.56	0.85	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	10.08	2.21	1.23	0.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	5.21	3.26	2.61	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	6.47	2.35	0.59	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	8.07	1.44	0.00	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	10.30	1.24	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	5.96	1.49	0.00	1.19
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	3.77	7.53	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	16.04	7.13	0.00	5.35
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	13.47	2.63	1.97	1.31
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	13.68	6.31	3.16	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	7.51	2.57	2.17	2.37
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	18.63	4.66	2.79	5.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	12.77	6.01	0.75	5.26
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	13.05	5.33	0.53	2.40
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	12.89	4.52	1.36	2.26
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	8.84	3.68	0.74	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	8.79	4.40	1.10	2.56
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	15.56	6.22	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	24.58	4.28	2.67	5.88
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	9.09	5.05	1.01	4.04
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	16.87	2.11	1.69	2.11
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	16.34	9.53	2.72	6.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	15.26	1.91	1.27	1.91
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	12.96	11.34	1.62	4.05
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	16.61	4.53	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	26.10	3.26	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	9.50	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	19.39	15.51	6.03	4.96
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	18.81	13.59	5.75	3.14
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	6.67	4.00	10.01	2.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	5.43	6.26	5.01	3.76
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	15.40	11.22	5.32	4.94
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	36.70	14.36	22.34	15.96
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	2.72	3.40	4.08	3.40
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	18.38	23.89	12.86	14.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	5.02	2.93	3.77	5.44
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	13.02	6.51	7.90	4.88
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	4.05	3.24	4.05	4.59
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	14.09	6.52	7.36	6.10
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	33.40	11.13	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	5.96	3.47	2.48	2.48
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	5.68	4.06	3.52	2.44
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	6.57	4.31	2.27	2.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	5.23	5.23	2.78	5.06
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	8.38	5.83	4.01	5.65
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	5.30	2.12	3.18	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	4.80	2.40	2.40	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	6.24	5.25	3.94	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	5.04	2.44	3.74	2.11
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	11.29	7.41	5.29	6.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.22	4.22	2.81	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	4.14	2.76	4.14	4.14
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	5.46	4.18	1.93	3.53
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	8.28	5.17	2.41	2.07
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	22.76	10.11	5.06	10.11
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	6.02	7.13	5.35	3.12
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	3.81	3.81	1.69	2.54
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	6.17	2.14	2.14	2.37
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	5.15	4.29	3.86	3.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	9.03	9.03	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	1.67	2.67	1.33	3.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	5.86	4.06	8.57	3.61
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	4.36	1.59	1.98	2.38
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	2.79	5.57	4.64	3.71
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	3.78	4.54	2.27	3.03
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	2.93	2.28	2.61	2.28
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	4.36	3.49	0.87	2.18
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	6.78	7.69	6.33	4.98
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	4.41	3.53	3.53	3.53
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	3.99	1.33	3.99	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	5.46	1.49	3.97	2.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	3.83	1.53	3.06	3.83
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	7.56	6.05	3.02	1.81
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	9.06	5.53	4.20	4.64
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	1.36	2.03	5.42	3.39
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	10.22	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	2.44	1.83	3.05	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	2.20	1.26	3.15	3.78
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	3.33	2.72	2.42	1.51
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	6.33	2.37	3.16	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	6.80	6.80	9.07	3.40
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	5.06	5.06	5.06
Myoblast, donor1	11241-116D8	26.34	8.70	6.09	3.85
Myoblast, donor2	11322-117D8	18.80	10.93	5.75	7.10
Myoblast, donor3	11398-118D3	24.05	11.60	6.22	6.22
NK T cell leukemia cell line:KHYG-1	10777-110G3	67.86	28.75	5.25	5.40
Natural Killer Cells, donor1	11230-116C6	27.37	11.07	1.23	4.61
Natural Killer Cells, donor2	11311-117C6	28.04	12.97	2.11	6.03
Natural Killer Cells, donor3	11387-118C1	30.74	10.68	2.21	3.31
Neural stem cells, donor1	11275-116H6	45.73	13.43	5.08	7.62
Neural stem cells, donor2	11352-117H2	36.59	36.59	19.26	21.18
Neurons, donor1	11494-119E9	58.03	38.69	23.90	25.03
Neurons, donor2	11574-120E8	24.88	37.65	18.93	21.14
Neurons, donor3	11655-122E8	34.53	41.11	22.20	21.38
Neutrophils, donor1	11233-116C9	12.06	6.50	1.86	1.86
Neutrophils, donor2	11314-117C9	23.19	2.90	5.80	5.80
Neutrophils, donor3	11390-118C4	4.28	3.05	0.00	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	12.70	9.26	4.63	2.85
Nucleus Pulposus Cell, donor2	11409-118E5	10.42	9.12	4.23	1.63
Nucleus Pulposus Cell, donor3	11462-119B4	18.05	13.04	6.82	7.22
Olfactory epithelial cells, donor1	11933-125I7	12.11	4.82	3.85	2.48
Olfactory epithelial cells, donor2	11934-125I8	13.90	8.97	3.76	2.32
Olfactory epithelial cells, donor3	11935-125I9	17.03	9.65	3.41	2.95
Olfactory epithelial cells, donor4	11936-126A1	11.98	9.16	4.68	2.05
Oligodendrocyte - precursors, donor1	11496-119F2	15.65	13.84	6.62	7.22
Osteoblast - differentiated, donor1	11276-116H7	14.04	10.21	5.53	4.68
Osteoblast - differentiated, donor2	11353-117H3	8.00	6.86	8.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	9.93	11.17	6.83	5.59
Osteoblast, donor1	11277-116H8	22.08	15.83	10.75	8.01
Osteoblast, donor2	11354-117H4	19.66	20.37	8.43	11.94
Osteoblast, donor3	11426-118G4	36.08	17.95	12.26	8.53
Pancreatic stromal cells, donor1	11249-116E7	33.19	14.91	8.76	5.90
Pericytes, donor1	11491-119E6	11.91	6.34	2.11	3.34
Pericytes, donor2	11571-120E5	15.17	7.92	2.26	4.98
Pericytes, donor3	11652-122E5	24.41	16.48	8.14	7.32
Perineurial Cells, donor1	11499-119F5	14.69	17.97	7.69	7.69
Perineurial Cells, donor2	11579-120F4	19.14	14.81	4.51	4.51
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	26.46	10.84	0.96	6.06
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	20.81	9.06	1.96	1.96
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	22.26	7.51	2.07	4.79
Placental Epithelial Cells, donor1	11278-116H9	4.07	4.07	1.91	3.59
Placental Epithelial Cells, donor2	11355-117H5	12.20	13.31	9.98	6.65
Placental Epithelial Cells, donor3	11427-118G5	10.99	6.87	3.34	4.52
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	11.71	4.43	3.16	2.85
Preadipocyte - breast, donor1	11467-119B9	19.51	7.69	6.19	2.63
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	11.36	5.09	3.13	2.48
Preadipocyte - breast, donor2	11328-117E5	21.39	9.46	4.05	4.95
Preadipocyte - omental, donor1	11468-119C1	23.12	10.66	6.82	4.90
Preadipocyte - omental, donor2	11329-117E6	9.60	4.80	3.49	4.36
Preadipocyte - omental, donor3	11403-118D8	20.20	11.75	5.73	3.72
Preadipocyte - perirenal, donor1	11469-119C2	26.58	5.91	5.91	8.86
Preadipocyte - subcutaneous, donor1	11279-116I1	30.10	10.75	3.69	4.61
Preadipocyte - subcutaneous, donor2	11356-117H6	34.35	16.82	7.44	7.44
Preadipocyte - subcutaneous, donor3	11428-118G6	31.50	16.18	6.98	8.51
Preadipocyte - visceral, donor1	11280-116I2	35.40	17.33	7.64	7.08
Preadipocyte - visceral, donor2	11357-117H7	26.23	11.50	6.44	10.12
Preadipocyte - visceral, donor3	11429-118G7	32.08	10.76	5.64	6.69
Prostate Epithelial Cells (polarized), donor1	11253-116F2	17.50	12.07	11.01	12.37
Prostate Epithelial Cells, donor2	11331-117E8	23.02	11.78	4.33	3.66
Prostate Epithelial Cells, donor3	11404-118D9	28.66	18.86	15.06	8.51
Prostate Stromal Cells, donor1	11254-116F3	27.11	13.67	7.97	5.24
Prostate Stromal Cells, donor2	11332-117E9	34.07	13.63	8.79	6.28
Prostate Stromal Cells, donor3	11405-118E1	18.04	9.91	4.17	2.92
Renal Cortical Epithelial Cells, donor1	11516-119H4	23.36	22.99	6.57	6.20
Renal Cortical Epithelial Cells, donor2	11596-120H3	30.50	19.34	6.86	6.31
Renal Epithelial Cells, donor1	11517-119H5	9.64	22.83	7.10	8.62
Renal Epithelial Cells, donor2	11597-120H4	21.34	22.76	8.54	9.96
Renal Epithelial Cells, donor3	11678-122H4	22.23	19.06	6.35	7.41
Renal Glomerular Endothelial Cells, donor1	11514-119H2	18.38	11.57	5.45	4.77
Renal Glomerular Endothelial Cells, donor2	11594-120H1	27.63	20.21	6.87	7.41
Renal Glomerular Endothelial Cells, donor3	11675-122H1	17.09	12.21	8.88	6.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	10.65	9.32	0.67	2.66
Renal Mesangial Cells, donor1	11518-119H6	22.01	14.97	4.62	8.80
Renal Mesangial Cells, donor2	11598-120H5	19.44	19.44	3.76	9.40
Renal Mesangial Cells, donor3	11679-122H5	11.37	13.32	4.16	5.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	35.16	19.06	7.52	10.74
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	27.83	13.92	10.12	4.22
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	22.37	15.81	6.94	9.26
Retinal Pigment Epithelial Cells, donor0	11215-116A9	28.78	22.56	7.26	5.44
Retinal Pigment Epithelial Cells, donor1	11528-119I7	13.64	15.06	3.70	6.25
Retinal Pigment Epithelial Cells, donor2	11608-120I6	8.23	11.32	2.06	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	28.60	20.07	8.78	6.27
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	5.48	2.41	1.07	1.07
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	4.47	2.68	3.57	4.47
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	7.15	2.75	1.65	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	9.28	5.80	1.16	3.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	7.15	4.03	3.77	3.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	8.74	4.77	3.38	2.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	8.81	7.03	3.12	3.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	9.68	5.83	3.23	3.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	8.74	5.13	3.50	3.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	13.64	5.32	4.62	2.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	5.34	4.52	3.15	2.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	7.87	4.99	2.72	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	10.57	5.38	3.58	2.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	5.31	4.45	3.01	2.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	8.16	5.69	2.90	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	9.96	6.42	2.43	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	5.35	2.87	2.87	3.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	7.64	3.91	3.45	3.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	7.52	5.45	3.57	3.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	7.56	3.18	3.98	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	9.15	4.67	2.14	3.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	10.50	4.20	4.01	2.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	6.19	3.63	2.99	2.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	6.17	2.24	2.24	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	8.54	3.59	3.42	3.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	6.38	2.92	2.01	3.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	6.01	3.43	3.31	2.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	11.28	5.51	3.63	3.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	6.37	2.83	1.89	2.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	5.56	4.17	3.17	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	8.42	7.72	3.04	2.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	6.01	2.28	0.83	2.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	10.18	6.64	2.88	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	7.10	5.01	3.34	3.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	6.06	2.42	3.63	2.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	6.30	3.24	3.07	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	7.90	5.78	2.31	2.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	5.50	2.24	2.58	2.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	5.62	3.98	2.06	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	10.51	3.94	2.63	3.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	4.43	3.41	1.70	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	8.43	6.21	3.55	4.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	4.53	5.06	2.67	2.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	11.75	5.53	3.04	3.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	7.62	4.29	4.76	4.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	7.26	5.24	3.83	4.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	6.31	3.30	2.26	3.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	12.58	7.69	3.84	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	6.95	4.23	6.35	2.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	3.30	2.57	2.20	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	11.06	6.70	3.49	3.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	7.30	6.08	8.52	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	3.92	2.71	2.71	2.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	7.92	2.04	3.17	2.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	7.19	2.40	2.40	3.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	4.01	2.60	1.77	2.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	5.55	3.20	2.35	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	7.81	4.21	1.80	2.40
Schwann Cells, donor1	11498-119F4	26.14	22.00	6.21	9.03
Schwann Cells, donor2	11578-120F3	20.41	37.43	13.61	10.21
Schwann Cells, donor3	11659-122F3	20.59	17.96	8.76	4.82
Sebocyte, donor1	11220-116B5	26.84	19.72	6.57	8.76
Sebocyte, donor2	11301-117B5	18.38	9.19	6.43	4.60
Sebocyte, donor3	11378-118B1	13.19	9.89	2.68	4.33
Sertoli Cells, donor1	11255-116F4	39.76	19.88	6.63	1.66
Sertoli Cells, donor2	11333-117F1	39.54	5.65	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	22.61	17.24	11.00	9.06
Skeletal Muscle Cells, donor2	11358-117H8	12.29	5.06	7.95	7.95
Skeletal Muscle Cells, donor3	11430-118G8	34.28	24.25	4.18	5.02
Skeletal Muscle Cells, donor4	11451-119A2	39.43	23.41	8.95	7.70
Skeletal Muscle Cells, donor5	11455-119A6	36.57	19.32	7.73	7.58
Skeletal Muscle Cells, donor6	11459-119B1	39.71	29.09	10.93	9.85
Skeletal Muscle Satellite Cells, donor1	11240-116D7	40.32	28.48	8.82	5.80
Skeletal Muscle Satellite Cells, donor2	11321-117D7	31.53	27.11	8.42	6.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	32.64	21.43	8.73	6.55
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	20.05	11.54	7.25	6.82
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	42.70	32.57	13.75	7.96
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	32.20	14.31	6.19	7.02
Skin - palm, donor1	10286-104F7	34.92	16.12	8.06	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	7.06	5.62	3.60	3.60
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	10.63	6.54	6.54	4.09
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	7.27	6.10	2.21	3.89
Small Airway Epithelial Cells, donor1	11256-116F5	34.61	26.13	9.73	7.09
Small Airway Epithelial Cells, donor2	11334-117F2	24.61	17.44	12.66	9.85
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	12.69	12.26	4.02	5.71
Small Airway Epithelial Cells, donor3	11406-118E2	24.28	18.44	14.17	8.39
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	40.12	21.91	13.58	8.33
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	20.45	4.67	4.00	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	22.93	12.93	8.23	7.05
Smooth Muscle Cells - Aortic, donor1	11283-116I5	33.81	8.84	3.54	1.55
Smooth Muscle Cells - Aortic, donor2	11360-117I1	28.75	22.84	6.69	4.73
Smooth Muscle Cells - Aortic, donor3	11432-118H1	26.27	11.59	11.59	7.73
Smooth Muscle Cells - Bladder, donor1	11519-119H7	6.00	7.01	3.00	4.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	29.28	15.84	8.52	6.39
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	33.69	9.97	5.10	2.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	51.60	23.43	12.55	7.94
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	19.54	16.61	1.95	5.86
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	14.47	12.99	3.84	3.25
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	17.37	9.68	2.14	4.41
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	19.20	12.69	5.04	5.69
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	16.13	11.26	7.00	3.65
Smooth Muscle Cells - Carotid, donor1	11285-116I7	26.77	17.43	3.28	6.06
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	12.24	6.12	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	27.66	11.92	2.86	6.68
Smooth Muscle Cells - Colonic, donor1	11239-116D6	22.71	12.39	5.31	4.57
Smooth Muscle Cells - Colonic, donor2	11320-117D6	29.27	12.05	5.60	5.38
Smooth Muscle Cells - Colonic, donor3	11396-118D1	28.02	14.48	6.19	4.83
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	38.36	22.12	9.13	6.34
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	50.66	23.71	17.25	9.70
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	26.90	11.36	8.67	6.57
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	15.70	9.56	3.07	3.41
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	20.26	14.61	4.32	1.96
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	23.55	9.86	5.23	2.62
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	21.85	12.29	4.55	3.87
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	39.25	20.53	9.06	3.02
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	22.78	20.40	7.42	6.09
Smooth Muscle Cells - Prostate, donor1	11257-116F6	23.04	12.65	5.73	4.26
Smooth Muscle Cells - Prostate, donor2	11335-117F3	27.80	11.52	4.88	3.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	12.94	10.40	2.79	4.06
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	34.07	22.16	8.29	6.94
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	27.76	7.50	6.75	3.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	122.76	12.92	6.46	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	15.81	14.42	2.79	4.65
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	24.23	9.09	8.08	3.03
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	21.31	4.70	5.64	1.88
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	15.93	9.44	4.13	5.90
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	33.99	23.91	8.16	6.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	14.95	11.21	5.14	4.67
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	33.10	18.57	7.77	6.48
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	48.19	18.10	6.88	6.63
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	43.06	22.56	11.66	9.40
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	20.26	24.18	5.73	6.57
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	17.68	21.95	8.13	6.87
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.38	5.71	5.71	2.38
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	23.49	17.86	8.56	6.36
Smooth Muscle Cells - Uterine, donor1	11258-116F7	22.54	13.48	7.29	5.52
Smooth Muscle Cells - Uterine, donor3	11466-119B8	31.89	13.46	5.85	4.10
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	9.33	5.83	1.17	2.53
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	20.10	6.88	5.29	4.23
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	9.67	4.46	1.86	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	18.33	8.62	4.67	2.16
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	21.01	9.94	4.83	4.54
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	32.30	14.57	11.42	4.73
Smooth muscle cells - airway, control, donor1	11966-126D4	12.70	6.86	1.78	1.78
Smooth muscle cells - airway, control, donor2	11967-126D5	7.59	6.79	4.39	2.00
Smooth muscle cells - airway, control, donor3	11968-126D6	10.03	4.60	2.93	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	19.25	8.25	3.67	0.46
Synoviocyte, donor1	11291-117A4	21.21	5.55	3.53	2.36
Synoviocyte, donor2	11368-117I9	20.45	10.23	3.35	3.86
Synoviocyte, donor3	11440-118H9	10.50	10.72	2.23	3.13
Trabecular Meshwork Cells, donor1	11532-120A2	16.79	23.58	7.86	8.22
Trabecular Meshwork Cells, donor2	11612-122A1	23.78	19.82	7.93	7.93
Trabecular Meshwork Cells, donor3	11693-123A1	17.13	17.13	3.47	4.63
Tracheal Epithelial Cells, donor1	11292-117A5	35.05	24.66	10.39	7.89
Tracheal Epithelial Cells, donor2	11369-118A1	22.03	14.69	4.64	3.48
Tracheal Epithelial Cells, donor3	11441-118I1	20.04	14.89	5.73	9.16
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	5.66	3.57	0.74	0.62
Urethra, donor2	10319-105A4	3.60	7.19	3.60	3.60
Urothelial Cells, donor1	11520-119H8	16.47	12.75	3.19	5.84
Urothelial Cells, donor2	11600-120H7	14.42	13.22	2.80	4.81
Urothelial Cells, donor3	11681-122H7	13.06	11.23	3.67	5.04
Urothelial cells, donor0	11216-116B1	19.84	17.83	7.13	6.24
Whole blood (ribopure), donor090309, donation1	12179-129A1	17.80	9.79	3.56	3.56
Whole blood (ribopure), donor090309, donation2	12180-129A2	20.01	7.15	2.86	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	12.32	1.37	0.00	2.74
Whole blood (ribopure), donor090325, donation1	12176-128I7	13.43	5.51	0.00	3.44
Whole blood (ribopure), donor090325, donation2	12177-128I8	18.59	6.39	1.74	2.91
Whole blood (ribopure), donor090612, donation1	12182-129A4	22.91	6.25	1.04	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	21.11	5.51	1.84	3.67
Whole blood (ribopure), donor090612, donation3	12184-129A6	17.35	5.48	2.74	7.30
Wilms' tumor cell line:G-401	10809-111A8	41.94	14.93	4.93	4.07
Wilms' tumor cell line:HFWT	10597-108E3	51.04	18.48	28.16	8.80
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	24.58	25.70	14.25	8.94
achilles tendon, donor2	10292-104G4	8.27	26.86	4.13	8.27
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	34.16	28.81	6.37	6.88
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	0.23	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	30.63	22.67	7.60	7.83
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	9.80	7.35	4.35	2.45
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	25.86	26.42	5.90	5.62
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	35.32	18.40	4.23	1.48
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	25.86	17.69	4.08	2.99
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	28.20	23.35	5.29	5.29
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	8.98	14.29	4.90	6.13
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	32.23	31.84	3.11	6.99
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	13.80	17.66	3.13	4.78
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	27.30	11.70	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	49.96	15.57	2.56	1.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	31.59	17.35	3.11	5.44
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	23.67	19.58	6.14	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	19.06	11.62	3.25	5.11
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	64.16	11.52	3.29	2.06
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	3.68	3.38	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	12.37	3.84	0.43	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	5.46	3.64	0.61	1.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	7.22	6.02	1.93	2.17
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	21.83	10.69	3.79	2.23
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	49.03	21.01	6.34	3.34
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	11.15	18.58	9.29	16.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	28.63	31.26	8.66	6.03
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	30.09	23.99	6.98	6.11
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	24.37	18.74	9.37	1.87
adenocarcinoma cell line:IM95m	10796-110I4	0.00	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	11.17	5.89	0.93	2.64
adipose, donor1	10184-103D4	46.33	28.73	4.10	4.10
adipose, donor2	10185-103D5	14.60	13.79	4.06	3.65
adipose, donor3	10186-103D6	23.14	13.89	5.99	5.99
adipose, donor4	10187-103D7	17.34	12.13	7.80	6.93
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	13.26	17.36	9.31	14.36
adrenal gland, adult, pool1	10081-102A9	3.64	3.64	0.00	7.28
adult T-cell leukemia cell line:ATN-1	10421-106C7	20.68	13.87	2.53	1.20
alveolar cell carcinoma cell line:SW 1573	10708-109H6	56.81	20.72	3.57	5.00
amniotic membrane cells, donor1	12235-129G3	8.35	7.65	4.64	9.04
amniotic membrane cells, donor2	12236-129G4	8.79	5.07	2.03	4.40
amniotic membrane cells, donor3	12237-129G5	12.08	8.54	5.01	6.78
amygdala - adult, donor10196	10167-103B5	18.97	17.79	5.93	8.30
amygdala, adult, donor10252	10151-102I7	22.51	16.42	5.68	5.88
amygdala, newborn, donor10223	10360-105E9	12.27	9.36	4.84	4.52
anaplastic carcinoma cell line:8305C	10428-106D5	34.89	51.95	43.80	24.96
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	31.33	11.69	2.65	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	17.37	19.37	6.01	7.35
aorta, adult, pool1	10052-101G7	6.28	6.28	4.51	2.35
appendix, adult	10189-103D9	8.54	10.09	4.27	2.72
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	8.60	29.92	9.63	7.91
artery, adult	10190-103E1	20.38	6.79	5.43	1.36
astrocytoma cell line:TM-31	10425-106D2	70.84	16.51	4.20	3.48
b cell line:RPMI1788	10427-106D4	15.61	20.37	2.68	1.19
basal cell carcinoma cell line:TE 354.T	10702-109G9	23.58	13.32	8.60	4.72
bile duct carcinoma cell line:HuCCT1	10432-106D9	45.94	23.91	7.34	4.17
bile duct carcinoma cell line:TFK-1	10496-107C1	14.39	4.85	4.52	1.51
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	17.90	14.54	3.36	3.36
bladder, adult, pool1	10011-101C2	8.26	5.87	1.52	1.63
blood, adult, pool1	10053-101G8	8.86	8.86	4.43	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	17.98	14.56	9.42	9.42
bone marrow, adult	10192-103E3	19.57	4.72	3.37	4.72
brain, adult, donor1	10084-102B3	22.55	11.28	4.10	5.13
brain, adult, pool1	10012-101C3	27.06	20.38	3.01	3.67
brain, fetal, pool1	10085-102B4	32.06	72.13	37.40	40.07
breast carcinoma cell line:MCF7	10482-107A5	37.00	22.13	5.95	6.28
breast carcinoma cell line:MDA-MB-453	10419-106C5	2.12	1.75	0.62	0.75
breast, adult, donor1	10080-102A8	1.89	1.89	5.05	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	37.35	27.44	7.62	9.02
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	32.78	25.05	7.42	7.73
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	42.82	16.81	3.45	8.29
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	9.20	10.17	2.42	1.21
carcinoid cell line:NCI-H1770	10703-109H1	22.10	41.37	14.58	18.81
carcinoid cell line:NCI-H727	10735-110B6	46.27	32.70	16.63	13.34
carcinoid cell line:SK-PN-DW	10719-109I8	7.92	21.55	8.56	4.75
carcinosarcoma cell line:JHUCS-1	10642-109A3	42.06	37.53	17.30	6.65
caudate nucleus - adult, donor10196	10177-103C6	24.18	10.36	3.45	1.15
caudate nucleus, adult, donor10252	10164-103B2	28.78	16.06	4.69	5.35
caudate nucleus, adult, donor10258	10379-105H1	43.56	21.40	5.35	6.11
caudate nucleus, newborn, donor10223	10354-105E3	14.65	6.59	2.56	4.39
cerebellum - adult, donor10196	10173-103C2	8.74	11.65	5.83	8.74
cerebellum, adult, donor10252	10166-103B4	15.59	13.88	6.19	5.55
cerebellum, adult, pool1	10083-102B2	27.60	18.63	5.52	4.14
cerebellum, newborn, donor10223	10357-105E6	9.96	8.30	3.32	4.98
cerebral meninges, adult	10188-103D8	43.87	20.42	5.80	5.29
cerebrospinal fluid, donor2	10294-104G6	18.27	9.50	2.92	6.58
cervical cancer cell line:D98-AH2	10552-107I3	70.60	37.96	6.61	4.46
cervical cancer cell line:ME-180	10553-107I4	46.73	24.36	10.94	5.63
cervix, adult, pool1	10013-101C4	8.40	6.93	3.36	3.15
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	20.34	18.53	8.36	11.43
chondrosarcoma cell line:SW 1353	10700-109G7	23.51	14.37	10.45	3.92
choriocarcinoma cell line:BeWo	10423-106C9	24.86	16.28	2.73	3.98
choriocarcinoma cell line:SCH	10785-110H2	17.50	9.73	5.79	4.19
choriocarcinoma cell line:T3M-3	10618-108G6	4.03	6.88	4.51	4.27
chorionic membrane cells, donor1	12238-129G6	2.85	3.42	2.28	3.13
chorionic membrane cells, donor2	12239-129G7	9.25	8.95	3.78	5.07
chorionic membrane cells, donor3	12240-129G8	4.95	3.30	3.30	5.49
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	23.23	8.08	1.01	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	21.71	15.94	3.65	4.03
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	19.85	17.32	4.01	4.86
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	4.11	11.04	2.31	2.57
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	7.26	11.85	2.66	3.39
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	5.70	8.96	2.04	1.83
chronic myelogenous leukemia cell line:K562	10454-106G4	20.02	13.25	2.94	3.53
chronic myelogenous leukemia cell line:KU812	10409-106B4	23.20	19.03	5.21	8.08
clear cell carcinoma cell line:JHOC-5	10638-108I8	40.00	25.83	7.31	13.94
clear cell carcinoma cell line:TEN	10636-108I6	91.61	25.68	4.68	5.21
colon carcinoma cell line:CACO-2	10513-107D9	27.82	16.11	14.46	17.76
colon carcinoma cell line:COLO-320	10420-106C6	43.71	57.77	12.16	12.16
colon, adult, donor1	10082-102B1	7.14	3.57	4.76	2.38
colon, adult, pool1	10014-101C5	7.76	6.11	2.00	1.65
colon, fetal, donor1	10070-101I7	4.94	2.47	3.09	1.85
common myeloid progenitor CMP, donor1	12130-128D6	36.67	87.09	18.33	45.84
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04	25.04	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	30.60	9.77	2.55	4.67
cord blood derived cell line:COBL-a 24h infection	10453-106G3	32.90	13.28	3.77	2.26
cord blood derived cell line:COBL-a untreated	10449-106F8	35.39	11.84	4.65	3.81
corpus callosum, adult, pool1	10042-101F6	32.51	16.92	8.07	4.09
cruciate ligament, donor2	10295-104G7	14.59	11.35	6.48	0.81
diaphragm, fetal, donor1	10069-101I6	10.43	3.21	1.61	2.41
diencephalon, adult	10193-103E4	29.04	12.00	6.96	4.56
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	39.26	33.52	7.12	6.20
ductal cell carcinoma cell line:KLM-1	10438-106E6	53.34	27.18	6.67	7.44
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	40.44	21.91	15.17	4.81
ductus deferens, adult	10196-103E7	11.96	5.98	3.99	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	10.08	0.00	2.88	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	20.60	5.89	3.68	2.21
dura mater, adult, donor1	10041-101F5	24.45	15.44	2.89	2.64
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	44.64	12.44	8.88	2.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	37.54	17.48	11.03	6.59
embryonic pancreas cell line:1B2C6	10604-108F1	27.75	24.05	6.78	14.18
embryonic pancreas cell line:1C3D3	10605-108F2	26.94	21.49	9.08	8.48
embryonic pancreas cell line:1C3IKEI	10606-108F3	36.74	18.83	12.35	9.26
embryonic pancreas cell line:2C6	10603-108E9	44.66	21.02	5.25	27.58
endometrial carcinoma cell line:OMC-2	10497-107C2	34.86	29.50	16.42	6.70
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	51.29	33.35	17.94	11.96
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	30.88	15.12	7.24	4.50
epidermoid carcinoma cell line:A431	10426-106D3	16.56	32.01	8.89	6.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	43.00	34.98	15.29	21.12
epididymis, adult	10197-103E8	15.70	6.91	2.93	2.72
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	43.47	17.56	4.08	4.97
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	24.38	6.29	1.57	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	20.05	6.55	2.36	2.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	18.01	9.05	2.07	2.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	22.85	9.52	3.25	2.24
esophagus, adult, pool1	10015-101C6	11.57	7.96	2.97	2.12
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	34.19	14.53	11.15	4.76
eye - muscle inferior rectus, donor1	10272-104E2	28.97	2.41	7.24	2.41
eye - muscle lateral, donor2	10298-104H1	18.94	10.52	4.21	4.21
eye - muscle medial, donor2	10299-104H2	14.88	8.93	2.98	1.49
eye - muscle superior, donor2	10297-104G9	18.34	11.46	4.59	6.88
eye - vitreous humor, donor1	10268-104D7	29.15	23.32	8.74	5.83
eye, fetal, donor1	10054-101G9	11.95	11.44	5.34	5.85
fibrosarcoma cell line:HT-1080	10758-110E2	37.06	15.77	4.36	3.97
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	13.06	15.19	9.26	8.55
frontal lobe, adult, pool1	10040-101F4	33.50	19.89	4.22	5.35
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	27.62	18.62	11.11	8.41
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	12.07	20.57	6.95	11.61
gall bladder, adult	10198-103E9	14.24	3.86	2.66	1.45
gamma delta positive T cells, donor1	11937-126A2	23.08	13.42	2.15	3.76
gamma delta positive T cells, donor2	11938-126A3	26.14	14.94	2.99	3.36
gastric adenocarcinoma cell line:MKN1	10614-108G2	20.70	15.84	7.39	2.32
gastric adenocarcinoma cell line:MKN45	10612-108F9	36.56	20.31	10.44	8.12
gastric cancer cell line:AZ521	10549-107H9	24.76	18.69	6.72	5.08
gastric cancer cell line:GSS	10560-108A2	20.13	21.97	12.81	14.64
gastrointestinal carcinoma cell line:ECC12	10615-108G3	13.94	11.19	9.82	5.71
giant cell carcinoma cell line:LU65	10487-107B1	7.34	8.84	6.31	7.00
giant cell carcinoma cell line:Lu99B	10433-106E1	24.07	33.73	4.48	5.60
glassy cell carcinoma cell line:HOKUG	10688-109F4	5.24	4.49	0.75	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	23.22	25.75	9.71	6.12
glioblastoma cell line:A172, tech_rep2	10444-106F3	23.17	23.59	8.99	7.30
glioblastoma cell line:T98G	10485-107A8	28.70	19.76	8.61	9.38
glioma cell line:GI-1	10413-106B8	11.13	10.84	7.61	7.61
globus pallidus - adult, donor10196	10175-103C4	18.95	13.12	5.10	5.83
globus pallidus, adult, donor10252	10161-103A8	20.50	11.47	7.57	3.66
globus pallidus, adult, donor10258	10367-105F7	24.65	16.43	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	15.99	8.53	3.20	4.26
granulocyte macrophage progenitor, donor1	12131-128D7	19.58	48.94	14.68	17.13
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	21.86	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	41.81	0.00	10.45
granulosa cell tumor cell line:KGN	10624-108H3	11.84	9.28	4.48	5.12
hIPS +CCl2, biol_rep1	14383-156B9	14.69	25.25	5.51	4.59
hIPS +CCl2, biol_rep2	14384-156C1	15.09	20.12	3.66	4.57
hIPS +CCl2, biol_rep3	14385-156C2	10.95	25.12	5.80	8.37
hIPS, biol_rep1	14380-156B6	4.31	7.19	2.87	5.75
hIPS, biol_rep2	14381-156B7	13.72	19.89	3.43	7.54
hIPS, biol_rep3	14382-156B8	20.97	35.31	2.21	8.83
hairy cell leukemia cell line:Mo	10712-109I1	23.85	21.55	6.90	3.45
heart - mitral valve, adult	10205-103F7	14.65	7.18	3.29	1.49
heart - pulmonic valve, adult	10206-103F8	15.43	5.49	1.31	1.31
heart - tricuspid valve, adult	10207-103F9	11.66	6.66	5.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	10.20	6.53	2.86	1.43
heart, adult, diseased, donor1	10051-101G6	16.18	7.66	0.85	1.70
heart, adult, pool1	10016-101C7	9.43	5.52	0.46	0.69
heart, fetal, pool1	10046-101G1	7.39	6.67	2.05	2.77
hepatic mesenchymal tumor cell line:LI90	10778-110G4	15.12	14.50	6.17	2.78
hepatoblastoma cell line:HuH-6	10633-108I3	19.03	21.41	17.84	9.51
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	38.01	23.54	10.06	14.59
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	35.44	22.58	13.11	14.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	39.41	22.53	10.21	12.33
hepatoma cell line:Li-7	10484-107A7	26.47	20.69	23.80	12.01
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	43.32	24.02	8.24	6.03
hippocampus - adult, donor10196	10169-103B7	28.39	17.03	8.52	8.52
hippocampus, adult, donor10252	10153-102I9	19.59	16.12	8.57	6.33
hippocampus, adult, donor10258	10374-105G5	24.90	18.92	1.99	5.48
hippocampus, newborn, donor10223	10363-105F3	22.91	10.22	7.75	5.64
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	38.45	35.40	15.26	21.97
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	22.19	21.80	11.39	10.80
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	29.20	28.69	10.92	11.68
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	29.88	19.17	2.82	5.64
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	23.24	19.62	2.32	4.65
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	38.72	24.30	2.66	4.18
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	41.17	15.18	2.92	5.55
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	34.90	11.42	3.45	7.11
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	34.20	12.93	2.09	4.17
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	46.41	21.55	3.79	4.97
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	31.98	16.71	4.50	4.82
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	40.40	22.22	4.04	5.39
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	28.01	24.57	13.77	10.64
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	30.95	28.99	13.26	10.32
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	45.38	24.44	6.98	5.24
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	24.82	12.41	3.25	4.01
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	21.37	14.83	0.87	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	25.99	17.49	3.50	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	25.06	13.19	2.83	3.58
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	24.55	19.10	4.09	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	26.31	17.85	3.45	4.39
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	27.92	12.25	3.10	3.92
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	34.55	13.64	3.48	2.90
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	32.88	13.15	2.99	3.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	29.56	24.94	14.04	10.16
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	21.11	27.10	14.83	10.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	43.69	28.58	17.56	8.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	27.11	14.08	1.76	5.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	23.76	13.30	1.90	2.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	29.96	16.95	1.82	4.24
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	26.89	6.72	4.65	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	27.89	16.60	5.31	6.64
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	38.48	14.62	4.36	4.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	36.81	16.36	3.58	2.81
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	32.56	15.14	4.54	8.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	40.66	16.13	3.36	4.37
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	29.46	24.63	14.01	10.38
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	35.65	25.85	8.47	8.91
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	27.32	31.22	8.78	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	25.67	13.14	5.20	3.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	97.60	55.31	6.51	13.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	31.77	23.83	2.98	3.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	27.36	16.97	0.55	2.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	32.57	10.49	3.26	3.26
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	38.08	16.37	3.91	3.56
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	38.19	20.29	0.00	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	47.53	18.28	4.06	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	38.52	14.01	2.42	3.23
immature langerhans cells, donor1	11904-125F5	16.22	8.72	3.39	6.30
immature langerhans cells, donor2	11905-125F6	26.93	13.47	4.75	9.51
insula, adult, pool1	10039-101F3	36.53	20.25	4.73	6.06
keratoacanthoma cell line:HKA-1	10791-110H8	12.68	9.75	5.53	6.50
kidney, adult, pool1	10017-101C8	18.32	9.01	2.60	2.80
kidney, fetal, pool1	10045-101F9	13.37	8.13	3.32	3.68
large cell lung carcinoma cell line:IA-LM	10509-107D5	12.21	16.05	4.69	7.53
large cell lung carcinoma cell line:NCI-H460	10839-111E2	22.12	17.28	4.70	4.70
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	18.90	18.72	9.91	7.89
left atrium, adult, donor1	10079-102A7	9.26	3.81	1.63	1.09
left ventricle, adult, donor1	10078-102A6	8.60	4.05	2.02	1.01
leiomyoblastoma cell line:G-402	10721-110A1	16.96	10.12	4.38	2.19
leiomyoma cell line:10964C	10569-108B2	30.54	12.93	2.87	2.16
leiomyoma cell line:15242A	10570-108B3	32.07	14.67	4.89	0.54
leiomyoma cell line:15425	10571-108B4	38.85	8.98	6.07	4.86
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	19.05	0.00	19.05
lens epithelial cell line:SRA 01/04	10647-109A8	26.14	13.59	10.46	6.27
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	10.39	20.31	6.61	6.97
liposarcoma cell line:KMLS-1	10782-110G8	20.31	8.59	6.09	7.97
liposarcoma cell line:SW 872	10726-110A6	25.10	22.91	8.04	10.36
liver, adult, pool1	10018-101C9	7.62	2.11	0.81	1.46
liver, fetal, pool1	10086-102B5	0.94	0.00	1.88	2.82
locus coeruleus - adult, donor10196	10182-103D2	24.50	18.08	7.58	3.65
locus coeruleus, adult, donor10252	10165-103B3	16.98	18.09	4.24	4.43
locus coeruleus, adult, donor10258	10375-105G6	21.16	14.39	4.80	3.10
locus coeruleus, newborn, donor10223	10362-105F2	8.41	3.79	3.79	2.94
lung adenocarcinoma cell line:A549	10499-107C4	33.21	19.38	10.10	14.25
lung adenocarcinoma cell line:PC-14	10408-106B3	11.03	22.06	4.83	2.76
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	14.50	10.28	1.85	2.11
lung, adult, pool1	10019-101D1	8.98	5.55	1.54	1.89
lung, fetal, donor1	10068-101I5	6.85	6.56	1.43	2.28
lung, right lower lobe, adult, donor1	10075-102A3	11.46	5.04	1.83	1.37
lymph node, adult, donor1	10077-102A5	12.31	6.63	3.79	1.42
lymphangiectasia cell line:DS-1	10727-110A7	19.73	14.47	3.07	2.19
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	16.15	22.19	7.40	5.58
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	7.65	9.34	9.34	9.34
mature adipocyte, donor1	12231-129F8	8.44	5.33	3.11	0.89
mature adipocyte, donor2	12232-129F9	15.15	4.57	1.04	0.62
mature adipocyte, donor3	12233-129G1	9.01	4.03	0.47	1.66
mature adipocyte, donor4	12234-129G2	9.74	3.69	0.79	1.32
maxillary sinus tumor cell line:HSQ-89	10414-106B9	27.88	36.22	14.77	15.96
medial frontal gyrus - adult, donor10196	10170-103B8	19.18	13.54	2.26	6.77
medial frontal gyrus, adult, donor10252	10150-102I6	29.98	13.98	4.23	4.97
medial frontal gyrus, adult, donor10258	10368-105F8	33.99	14.93	4.13	5.72
medial frontal gyrus, newborn, donor10223	10352-105E1	26.87	15.78	4.69	8.53
medial temporal gyrus - adult, donor10196	10183-103D3	33.08	16.20	4.89	5.06
medial temporal gyrus, adult, donor10252	10156-103A3	27.16	13.37	4.03	2.76
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	19.26	13.48	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	57.41	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	10.05	9.69	3.95	6.46
medulla oblongata - adult, donor10196	10174-103C3	19.47	9.09	5.19	2.60
medulla oblongata, adult, donor10252	10155-103A2	20.28	12.54	6.04	4.49
medulla oblongata, adult, pool1	10038-101F2	30.86	20.33	5.47	3.75
medulla oblongata, newborn, donor10223	10361-105F1	15.62	4.86	2.78	2.08
medulloblastoma cell line:D283 Med	10838-111E1	18.60	42.07	11.73	4.65
medulloblastoma cell line:ONS-76	10759-110E3	33.75	34.48	17.00	14.55
melanoma cell line:COLO 679	10514-107E1	25.59	13.66	5.32	7.19
melanoma cell line:G-361	10465-106H6	56.46	18.73	3.53	1.63
meningioma cell line:HKBMM	10691-109F7	19.36	18.09	7.60	5.79
merkel cell carcinoma cell line:MKL-1	10843-111E6	37.01	33.48	6.17	5.29
merkel cell carcinoma cell line:MS-1	10844-111E7	34.48	21.77	5.44	1.56
mesenchymal precursor cell - adipose, donor1	11747-123G1	47.72	16.42	7.83	6.60
mesenchymal precursor cell - adipose, donor2	11748-123G2	31.08	10.00	10.18	5.64
mesenchymal precursor cell - adipose, donor3	11749-123G3	39.34	12.84	5.80	3.31
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	27.11	9.55	5.48	3.65
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	12.13	6.35	3.27	4.24
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	20.82	4.16	2.78	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	23.51	9.10	8.92	7.04
mesenchymal precursor cell - cardiac, donor2	11753-123G7	24.04	8.97	5.18	6.56
mesenchymal precursor cell - cardiac, donor3	11754-123G8	33.56	12.07	6.23	7.03
mesenchymal precursor cell - cardiac, donor4	11755-123G9	27.01	13.23	8.10	7.97
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	26.18	12.66	11.10	8.11
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	28.32	9.88	9.22	4.94
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	32.93	14.11	8.58	8.03
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	45.03	18.15	11.17	8.73
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	22.66	13.68	9.80	10.21
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	12.58	10.78	6.11	4.67
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	16.55	10.03	5.07	9.62
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	20.06	5.93	5.70	4.33
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	59.16	19.30	13.01	7.55
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	23.91	7.62	4.33	5.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	26.52	12.78	11.29	12.69
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	17.67	10.68	9.94	9.57
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	14.59	8.87	7.44	6.30
mesenchymal stem cell line:Hu5/E18	10568-108B1	24.42	14.74	6.32	7.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	21.92	11.42	6.39	6.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	21.23	10.74	4.86	4.60
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	21.73	8.64	7.07	4.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	21.57	9.86	3.70	3.70
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	24.71	8.71	7.53	4.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	18.95	9.48	5.75	5.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	25.54	8.25	5.11	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	23.17	7.88	6.02	4.63
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	29.71	8.94	6.06	4.61
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	25.88	8.92	6.69	3.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	28.12	10.82	6.01	6.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	27.13	16.13	5.87	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	25.85	8.39	6.71	3.02
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	27.84	9.83	6.55	2.87
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	21.91	5.15	6.01	3.87
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	30.08	8.20	5.47	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	15.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	31.50	12.02	4.87	4.55
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	14.55	10.18	11.64	5.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	24.52	12.79	5.86	4.26
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	33.53	5.72	4.09	4.09
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	22.93	8.55	3.89	5.44
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	27.28	6.30	2.10	6.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	20.86	8.94	2.98	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	4.77	9.53	9.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	23.72	10.67	4.15	4.15
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	19.50	13.40	6.09	4.87
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	23.44	11.40	5.07	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	19.66	12.76	4.48	3.79
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	12.90	0.00	12.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	0.00	11.98	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	0.00	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	11.41	4.89	4.48	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.15	10.33	3.97	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	2.95	5.90	3.54	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	5.92	5.92	2.81	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	2.67	6.68	4.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	8.28	5.91	5.91	7.10
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	0.00	7.70	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	6.88	12.39	4.13	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	10.89	8.41	1.48	4.95
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	8.97	3.36	1.12	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	13.99	6.36	5.72	2.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	13.70	6.45	2.01	5.24
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	2.18	2.18	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	6.34	3.80	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	8.50	1.21	2.43	3.64
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	9.04	9.04	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	9.06	7.41	1.65	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	7.34	5.16	1.98	2.78
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	7.14	4.87	2.60	1.62
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	6.11	3.06	3.06	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	10.06	6.19	3.87	3.87
mesothelioma cell line:ACC-MESO-1	10493-107B7	17.72	26.46	12.99	20.08
mesothelioma cell line:ACC-MESO-4	10494-107B8	3.71	5.33	1.62	2.09
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	29.92	0.00	12.82
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	20.96	11.51	4.93	2.36
mesothelioma cell line:Mero-25	10850-111F4	27.23	19.52	14.53	7.04
mesothelioma cell line:Mero-41	10851-111F5	32.27	26.89	8.31	7.58
mesothelioma cell line:Mero-48a	10852-111F6	26.35	15.06	6.20	3.76
mesothelioma cell line:Mero-82	10853-111F7	19.71	19.45	10.25	6.31
mesothelioma cell line:Mero-83	10854-111F8	28.26	17.19	8.34	4.26
mesothelioma cell line:Mero-84	10855-111F9	16.68	14.66	5.81	4.80
mesothelioma cell line:Mero-95	10856-111G1	17.60	18.84	4.14	9.11
mesothelioma cell line:NCI-H2052	10847-111F1	54.00	37.11	19.05	15.74
mesothelioma cell line:NCI-H226	10846-111E9	36.02	13.57	6.15	5.61
mesothelioma cell line:NCI-H2452	10848-111F2	24.43	22.38	7.86	4.44
mesothelioma cell line:NCI-H28	10845-111E8	11.45	13.49	4.07	6.36
mesothelioma cell line:No36	10857-111G2	30.01	26.75	9.13	8.16
mesothelioma cell line:ONE58	10858-111G3	20.05	10.84	2.44	1.08
migratory langerhans cells, donor1	11901-125F2	41.46	11.90	2.49	6.33
migratory langerhans cells, donor2	11902-125F3	19.78	9.28	3.54	3.79
migratory langerhans cells, donor3	11903-125F4	27.46	14.90	3.59	3.59
mixed mullerian tumor cell line:HTMMT	10689-109F5	34.28	19.92	20.89	16.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	48.53	14.84	4.87	5.93
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	38.47	21.42	14.97	8.52
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	17.70	9.51	2.47	4.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	44.90	25.13	6.10	4.07
myeloma cell line:PCM6	10474-106I6	43.49	10.28	1.58	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	65.44	30.94	23.84	14.20
myxofibrosarcoma cell line:NMFH-1	10684-109E9	34.91	15.30	6.67	5.69
nasal epithelial cells, donor1, tech_rep1	12226-129F3	15.93	21.50	13.15	9.25
nasal epithelial cells, donor1, tech_rep2	12226-129F3	20.66	20.89	11.62	8.16
nasal epithelial cells, donor2	12227-129F4	19.32	25.39	8.28	7.73
neuroblastoma cell line:CHP-134	10508-107D4	27.84	34.28	7.59	7.13
neuroblastoma cell line:NB-1	10539-107G8	65.48	37.42	6.74	8.79
neuroblastoma cell line:NBsusSR	10607-108F4	18.14	47.45	28.47	24.67
neuroblastoma cell line:NH-12	10555-107I6	48.82	67.65	10.99	8.76
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	6.64	11.62	7.83	6.41
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	3.17	9.19	3.01	5.86
neuroectodermal tumor cell line:TASK1	10774-110F9	17.11	20.33	5.03	2.21
neuroepithelioma cell line:SK-N-MC	10728-110A8	3.18	19.07	6.36	10.81
neurofibroma cell line:Hs 53.T	10729-110A9	19.43	12.78	9.85	6.12
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	13.28	0.00
neutrophil PMN, donor3	12141-128E8	0.00	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	5.41	19.45	3.04	5.24
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	60.84	60.84	22.41	12.81
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	13.47	9.62	6.41	2.24
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	21.28	8.41	3.42	3.15
nucleus accumbens, adult, pool1	10037-101F1	34.50	18.75	4.31	5.62
occipital cortex - adult, donor10196	10172-103C1	30.91	10.30	2.06	6.18
occipital cortex, adult, donor10252	10163-103B1	16.10	13.42	2.68	4.83
occipital cortex, newborn, donor10223	10355-105E4	13.83	9.83	3.64	5.82
occipital lobe, adult, donor1	10076-102A4	31.49	20.73	7.61	6.82
occipital lobe, fetal, donor1	10073-102A1	39.05	48.92	39.48	31.75
occipital pole, adult, pool1	10036-101E9	34.53	22.23	2.92	4.42
olfactory region, adult	10195-103E6	31.91	19.30	4.39	6.11
optic nerve, donor1	10277-104E7	68.04	32.02	8.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	44.42	24.72	12.87	8.20
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	22.81	42.59	7.56	8.38
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	15.07	15.58	7.45	5.42
oral squamous cell carcinoma cell line:SAS	10544-107H4	22.52	14.79	5.31	6.70
osteoclastoma cell line:Hs 706.T	10704-109H2	28.81	10.58	9.99	7.35
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	27.10	38.31	14.95	14.02
osteosarcoma cell line:HS-Os-1	10558-107I9	8.06	8.06	6.15	4.67
ovary, adult, pool1	10020-101D2	7.77	7.60	3.93	3.14
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	19.98	25.11	21.08	10.82
pancreas, adult, donor1	10049-101G4	27.28	4.70	1.88	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	16.77	17.33	8.95	6.99
papillary adenocarcinoma cell line:8505C	10437-106E5	57.75	53.32	28.11	19.42
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	30.47	10.43	2.98	2.15
paracentral gyrus, adult, pool1	10035-101E8	35.79	23.06	3.48	4.21
parietal cortex, adult, donor10258	10373-105G4	29.36	15.41	2.94	5.87
parietal lobe - adult, donor10196	10171-103B9	28.21	15.99	3.76	5.64
parietal lobe, adult, donor10252	10157-103A4	27.93	16.53	2.57	2.85
parietal lobe, adult, pool1	10034-101E7	30.93	22.12	6.26	5.29
parietal lobe, fetal, donor1	10072-101I9	45.58	57.22	27.16	32.97
parietal lobe, newborn, donor10223	10356-105E5	14.95	12.71	5.61	3.36
parotid gland, adult	10199-103F1	21.58	8.02	0.62	0.62
penis, adult	10200-103F2	14.50	9.13	1.61	2.69
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	7.62	13.95	5.76	3.72
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	20.69	10.93	3.64	3.35
pineal gland - adult, donor10196	10179-103C8	17.42	14.84	4.52	4.52
pineal gland, adult, donor10252	10160-103A7	21.32	24.28	11.25	3.55
pineal gland, adult, donor10258	10377-105G8	28.22	20.69	6.27	1.88
pituitary gland - adult, donor10196	10180-103C9	23.27	22.26	9.11	7.08
pituitary gland, adult, donor10252	10162-103A9	27.10	22.41	12.51	16.16
pituitary gland, adult, donor10258	10378-105G9	41.71	28.94	10.21	11.07
placenta, adult, pool1	10021-101D3	6.02	4.09	0.75	0.86
plasma cell leukemia cell line:ARH-77	10840-111E3	22.64	22.25	5.16	3.71
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	12.30	12.45	4.98	4.98
pons, adult, pool1	10033-101E6	32.02	17.82	5.25	4.05
postcentral gyrus, adult, pool1	10032-101E5	35.39	24.67	4.79	5.14
promyelocytes/myelocytes PMC, donor1	12132-128D8	10.46	27.19	6.27	6.27
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	22.03	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	11.74
prostate cancer cell line:DU145	10490-107B4	19.23	11.22	3.06	1.89
prostate cancer cell line:PC-3	10439-106E7	23.60	41.02	20.15	12.34
prostate, adult, pool1	10022-101D4	8.71	5.53	2.09	1.18
putamen, adult, donor10196	10176-103C5	36.83	17.47	3.78	8.73
putamen, adult, donor10252	10152-102I8	19.61	21.57	3.92	5.88
putamen, adult, donor10258, tech_rep1	10372-105G3	15.30	17.48	1.09	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	35.52	20.30	2.90	7.01
putamen, newborn, donor10223	10365-105F5	12.74	3.75	1.50	0.75
rectal cancer cell line:TT1TKB	10469-106I1	18.62	22.11	11.06	9.02
rectum, fetal, donor1	10067-101I4	15.30	8.35	1.39	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	62.12	32.22	15.05	12.30
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	10.77	17.81	11.60	10.77
retina, adult, pool1	10030-101E3	17.99	16.80	4.77	3.68
retinoblastoma cell line:Y79	10475-106I7	54.82	36.89	2.86	6.24
rhabdomyosarcoma cell line:KYM-1	10787-110H4	17.46	13.03	3.93	4.18
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	22.78	20.25	15.18	5.34
sacrococcigeal teratoma cell line:HTST	10695-109G2	15.16	13.64	6.06	5.30
salivary acinar cells, donor1	11771-123I7	16.67	16.35	4.05	3.56
salivary acinar cells, donor2	11772-123I8	19.83	16.38	3.44	1.38
salivary acinar cells, donor3	11773-123I9	15.23	15.23	8.61	3.97
salivary gland, adult, pool1	10093-102C3	29.74	9.72	2.86	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	27.32	7.34	3.04	1.77
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	28.68	10.34	3.17	1.41
seminal vesicle, adult	10201-103F3	13.23	10.05	1.59	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	14.09	7.04	4.13	8.26
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	25.92	24.16	13.59	24.66
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	40.14	26.09	18.06	13.05
serous cystadenocarcinoma cell line:HTOA	10693-109F9	28.48	17.60	11.28	9.67
signet ring carcinoma cell line:Kato III	10436-106E4	0.11	0.00	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	18.71	6.71	1.68	0.90
skeletal muscle - soleus muscle, donor1	10282-104F3	32.63	6.38	2.84	1.42
skeletal muscle, adult, pool1	10023-101D5	19.07	5.16	2.76	1.32
skeletal muscle, fetal, donor1	10066-101I3	4.02	4.02	3.02	2.01
skin, adult, donor1	10074-102A2	0.00	27.14	0.00	6.79
skin, fetal, donor1	10065-101I2	10.10	5.68	4.42	3.79
small cell cervical cancer cell line:HCSC-1	10800-110I8	35.35	30.68	6.00	12.01
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	53.27	35.93	16.71	9.14
small cell lung carcinoma cell line:DMS 144	10841-111E4	4.24	8.10	1.93	2.31
small cell lung carcinoma cell line:LK-2	10541-107H1	37.09	36.59	6.43	2.64
small cell lung carcinoma cell line:NCI-H82	10842-111E5	19.30	83.48	19.46	19.46
small cell lung carcinoma cell line:WA-hT	10562-108A4	60.15	26.59	9.15	7.63
small intestine, adult, pool1	10024-101D6	12.06	4.54	2.39	2.15
small intestine, fetal, donor1	10064-101I1	6.88	4.91	2.46	4.42
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	22.57	18.98	6.67	10.77
smooth muscle, adult, pool1	10048-101G3	9.30	4.91	2.84	1.29
somatostatinoma cell line:QGP-1	10781-110G7	80.14	33.77	14.21	8.04
spinal cord - adult, donor10196	10181-103D1	24.55	13.53	7.57	1.84
spinal cord, adult, donor10252	10159-103A6	13.01	12.62	4.34	3.94
spinal cord, adult, donor10258	10369-105F9	25.60	12.45	6.23	3.46
spinal cord, fetal, donor1	10056-101H2	27.44	22.56	10.98	9.15
spinal cord, newborn, donor10223	10359-105E8	17.91	9.18	1.84	3.21
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	30.62	15.08	11.65	7.32
spleen, adult, pool1	10025-101D7	13.22	5.84	1.76	3.41
spleen, fetal, pool1	10044-101F8	9.38	5.16	1.67	2.94
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	23.08	16.04	5.59	2.69
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	61.14	23.16	7.78	7.78
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	13.63	6.64	3.84	3.49
squamous cell carcinoma cell line:T3M-5	10616-108G4	41.05	46.13	40.66	14.46
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	30.62	10.92	4.95	6.53
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	23.72	24.15	11.86	5.08
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	17.35	10.58	6.35	3.81
stomach, fetal, donor1	10062-101H8	18.16	10.68	3.20	7.48
submaxillary gland, adult	10202-103F4	20.51	7.41	2.28	1.14
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	17.24	12.88	6.23	3.32
substantia nigra, adult, donor10258	10371-105G2	35.17	23.79	3.10	5.69
substantia nigra, newborn, donor10223	10358-105E7	8.48	5.65	2.83	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	5.04	11.92	4.81	7.80
temporal lobe, adult, pool1	10031-101E4	36.37	18.82	5.09	4.92
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	25.64	54.84	34.19	37.75
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	26.37	50.99	28.13	29.45
tenocyte, donor1	11763-123H8	18.50	5.24	6.63	6.28
tenocyte, donor2	11765-123I1	14.12	6.49	6.87	3.43
tenocyte, donor3	11768-123I4	20.39	12.60	6.30	7.41
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	28.55	14.45	3.91	3.91
teratocarcinoma cell line:NCR-G1	10798-110I6	43.32	18.34	5.86	5.09
teratocarcinoma cell line:PA-1	10807-111A6	38.12	24.95	6.97	5.42
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	15.11	24.12	17.14	9.39
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	31.77	40.09	17.77	18.91
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	31.41	18.76	10.69	9.27
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	41.69	31.27	5.86	6.84
testis, adult, pool1	10026-101D8	16.96	9.88	4.29	2.47
testis, adult, pool2	10096-102C6	28.42	24.36	7.67	6.32
thalamus - adult, donor10196	10168-103B6	26.50	16.56	5.52	5.52
thalamus, adult, donor10252	10154-103A1	19.38	12.19	3.44	3.13
thalamus, adult, donor10258, tech_rep1	10370-105G1	20.02	18.48	7.70	9.24
thalamus, adult, donor10258, tech_rep2	10370-105G1	12.52	7.58	2.14	1.81
thalamus, newborn, donor10223	10366-105F6	14.96	6.90	3.45	1.73
throat, adult	10209-103G2	12.48	9.24	2.75	3.25
throat, fetal, donor1	10061-101H7	14.93	7.31	3.35	7.62
thymic carcinoma cell line:Ty-82	10803-111A2	13.51	17.09	4.17	5.17
thymus, adult, pool1	10027-101D9	5.47	3.28	0.99	0.80
thymus, fetal, pool1	10043-101F7	3.12	2.08	1.35	0.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	43.74	32.58	23.40	16.09
thyroid carcinoma cell line:TCO-1	10783-110G9	37.86	45.68	37.44	24.17
thyroid, adult, pool1	10028-101E1	10.73	10.73	3.64	4.29
thyroid, fetal, donor1	10060-101H6	11.60	8.96	3.95	2.90
tongue epidermis (fungiform papillae), donor1	10288-104F9	21.56	15.40	0.00	0.00
tongue, adult	10203-103F5	24.89	12.09	4.19	2.09
tongue, fetal, donor1	10059-101H5	8.67	5.52	3.55	3.15
tonsil, adult, pool1	10047-101G2	16.43	11.42	3.11	3.01
trachea, adult, pool1	10029-101E2	11.37	7.93	2.04	3.03
trachea, fetal, donor1	10058-101H4	6.92	5.39	2.69	3.85
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	31.53	14.88	7.79	4.96
transitional-cell carcinoma cell line:5637	10418-106C4	32.12	27.15	10.23	9.42
transitional-cell carcinoma cell line:JMSU1	10492-107B6	28.99	18.18	7.68	6.11
tridermal teratoma cell line:HGRT	10694-109G1	26.64	28.54	7.61	9.51
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	14.48	11.00	5.50	5.84
umbilical cord, fetal, donor1	10057-101H3	12.52	12.52	2.09	2.09
uterus, adult, pool1	10100-102D1	15.36	10.24	5.29	5.29
uterus, fetal, donor1	10055-101H1	10.75	9.73	7.68	4.61
vagina, adult	10204-103F6	6.46	3.23	5.17	1.94
vein, adult	10191-103E2	13.37	7.45	2.63	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	12.02	8.55	2.67	3.74